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 Attentional dysfunction is associated with numerous genetic and 
environmental factors that disrupt brain development. Evidence implicates 
catecholaminergic systems in attentional processing, suggesting that alterations in 
catecholamine neurochemistry may underlie these attentional dysfunctions.  The goal 
of the present experiments was to use a pharmacological challenge approach to 
examine underlying neural changes that relate to attentional dysfunctions induced by 
two developmental insults, lead (Pb) exposure and prenatal cocaine exposure, and to 
test the hypothesis that exposure-induced alterations in catecholaminergic systems 
contribute to these attentional deficits.  In each experiment, adult rats were 
administered a visual attention task which assessed subjects’ ability to monitor an 
unpredictable light cue and maintain performance when presented with olfactory 
distractors.  In the first study, Pb-exposed subjects demonstrated significant 
impairments in accuracy relative to controls, providing evidence for Pb-induced 
attentional dysfunction. The alpha-2 adrenergic antagonist idazoxan improved 
accuracy, specifically in the most attentionally demanding conditions.  However, this 
effect of idazoxan did not differ between Pb-exposed and control subjects, failing to 
support the hypothesis that the attentional dysfunction was due to alterations in 
 noradrenergic systems.  In the second study, prenatal cocaine-exposed subjects did not 
differ from controls in their response to idazoxan’s effect on errors of commission, but 
were more sensitive to idazoxan’s effects on errors of omission and nontrials.  The 
pattern of effects suggested that the differential treatment response to idazoxan 
resulted from prenatal cocaine-induced alterations in norepinephrine-modulated 
dopamine release, reflecting lasting changes in dopaminergic and/or noradrenergic 
systems underlying attention.  The final study was designed to assess whether cocaine 
exposed and control subjects differ in sensitivity to attentional effects of the D1 
dopamine agonist SKF81297.  Prenatal cocaine-exposed subjects were more sensitive 
to the impairing effects of SKF81297 on errors of omission, providing specific 
evidence that prenatal cocaine exposure produces lasting changes in dopaminergic 
systems mediating attention.  In conclusion, environmental Pb exposure impairs 
attention; however, these impairments do not appear to reflect alterations in 
noradrenergic function, suggesting the involvement of other neurochemical systems.  
In contrast, prenatal cocaine-induced attentional impairments appear to be related to 
lasting changes in dopaminergic systems underlying attention, suggesting possible 
targets for pharmacotherapeutic intervention in affected children. 
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CHAPTER ONE 
INTRODUCTION 
 
Attentional systems as a target of toxicity 
 Deficits in attention are among the most common impairments seen in 
developmental disorders, and are associated with a wide variety of genetic and 
environmental factors that disrupt brain development.   Attentional dysfunction is a 
commonly cited consequence of unrelated disorders such as attention deficit 
hyperactivity disorder (ADHD) (reviewed in Karatekin, 2001), fragile X syndrome 
(Baumgardner, et al, 1995; Hagerman, 1996; Lachiewicz, et al, 1994; Largo and 
Schinzel, 1985; Moon, et al, 2006; Turk, 1998),  Down syndrome (Brown et al, 2003; 
Driscoll, et al, 2004; Tomporowski, et al, 1990; Wilding et al, 2002), phenylketonuria 
(PKU) (Diamond, 2001; Pennington, et al, 1985), and conditions caused by exposure 
to a variety of substances such as environmental toxins and drugs of abuse. The 
prevalence of attentional impairments as a symptom of early insult relative to other 
types of cognitive impairment suggests that the attentional processing system appears 
to have increased vulnerability to disruption by genetic and environmental factors 
(Pennington, 1991).  This differential vulnerability is likely due to the evolutionary 
history, developmental time-course, and neurochemical modulation of the prefrontal 
cortex (PFC), a critical brain region for attentional processing 
 
Prefrontal control of attentional function 
Considerable evidence suggests that the PFC mediates attentional processing, 
including both selective and sustained attention. Lesions to the PFC in human patients 
(Chao and Knight, 1995; Knight, et al, 1995; Mennemeir, et al, 1994; Ptito, et al, 
1995; Rueckert and Grafman, 1996; Wilkins, et al, 1987), monkeys (Stuss and 
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Benson, 1986) and rats (Chudasama, et al, 2003; Muir, et al 1996; Passetti, et al, 2002; 
2003) cause deficits in sustained attention, and increased distractibility to irrelevant 
stimuli in auditory, visual, and haptic modalities. Dorsolateral prefrontal patients 
(Eslinger and Grattan, 1993; Milner, 1995; Owen, et al, 1991), marmosets with 
dorsolateral prefrontal lesions (Dias, et al, 1996; 1997), and rats with lesions to the 
medial PFC (Birrell, et al, 2000) show deficits in the ability to shift attentional set to a 
previously irrelevant dimension.  Human patients with lesions to the dorsolateral PFC 
are also impaired on tasks of divided attention (Godefroy, et al, 1996) and on 
performance of the Stroop task, a task of attentional selection and response inhibition 
(Stuss, et al., 2001; Vendrell, et al, 1995).  
The prefrontal cortex shows selective activation during performance of 
attentional tasks.  Human functional neuroimaging studies have demonstrated specific 
frontal activation during the performance of the continuous performance task (CPT), a 
standard test of visual sustained attention and response inhibition (Rezai, et al, 1993). 
Differences in frontal evoked potentials produced in response to relevant target stimuli 
versus irrelevant distractor stimuli during visual and auditory attention tasks have also 
been reported (Baudena, et al, 1995; Zani, 1995). Dorsolateral prefrontal activation 
has been reported during shifting of attention between spatial locations (Corbetta, et 
al, 1993), between sorting categories on the Wisconsin Card Sorting Task (Konishi, et 
al, 1999; Rezai, 1993), and between competing tasks during dual-task performance 
(D’Esposito, et al, 1995; Loose, et al, 2003). Dorsolateral prefrontal activation has 
also been demonstrated during performance of the Stroop task, with greater activation 
exhibited on more attentionally demanding trials (Banich, 2000).  Single-unit 
recordings from rhesus monkey dorsolateral PFC have identified a population of 
neurons that increased activity levels during the delay (or attention-demanding) period 
of a visual target detection task in which difficulty was manipulated by altering the 
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size and color contrast of the target (Lecas, 1995). Although these neurons were active 
during the delay under all conditions, average firing rate was proportional to 
attentional demand. Firing rate was highest in the difficult blocks, and lowest in the 
easy blocks, suggesting that these neurons control or code for the level of attention of 
the animal. Increases in unit activity of neurons in PFC under conditions of enhanced 
attentional demand have also been reported in rats during performance of sustained 
visual attention tasks in which visual distractors were presented (Gill, et al, 2000). 
The critical role of the PFC in attentional processing may provide insight into the 
differential vulnerability of this functional brain system.  The relatively large size of 
the human PFC occurred late in evolutionary history, and maturation of this brain 
region occurs relatively late in brain development; both factors which can increase 
susceptibility to developmental disruption (Pennington, 1991). Prefrontal control of 
attention relies on multiple neurotransmitter systems, making this system vulnerable to 
a variety of different neurochemical insults. Finally, evidence suggests that the 
dopamine (DA) neurons in this brain area have a greater dependence on precursor 
availability than those of other brain systems (Tam, et al, 1990), providing an 
additional mechanism for the greater vulnerability of this region. 
 
Evolutionary History 
The large prefrontal cortices of primates, especially humans, are a recent 
development in evolutionary history.  Both the absolute and relative size of this brain 
region have increased significantly over recent evolution.  According to Lieberman 
(1984), recently evolved brain systems tend to demonstrate a higher level of genetic 
variation both within and across species when compared to evolutionarily older, more 
highly conserved brain systems. Thus, the prefrontal attentional system’s recent 
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evolutionary history should result in greater variation and, consequently greater 
vulnerability to developmental pathologies (Pennington, 1991). 
 
Late development compared to other brain systems 
A second relevant feature of the PFC is its protracted developmental time-
course.  The PFC is the last brain region to develop in humans and does not reach full 
maturity until early adulthood (Huttenlocher, et al, 1979, 1982, 1984, 1990; Rosenberg 
and Lewis, 1994; Sowell, et al, 1999; Thatcher, et al, 1987; Yakovlev, et al 1967). 
Thus, childhood exposure to toxins may cause alterations in this prefrontal attentional 
system while sparing other brain systems that are more fully developed at the time of 
exposure.  Recent studies also suggest that the first two years, especially the second 
half of the first year of life, is an important transition period in prefrontal cortical 
anatomical development. Studies show that specific changes in and maturation of 
prefrontal cortical neurons and their associated cognitive functions are occurring 
during this period (Diamond, 2002).  During this period, both the levels of DA 
(Brown, et al, 1977) and density of DA receptors increase (Lidow and Rakic, 1991) in 
dorsolateral PFC and significant changes occur in the distribution of tyrosine 
hydroxylase containing axons in this brain region (Lewis and Harris, 1991; Rosenberg 
and Lewis, 1995) in rhesus macaques. These neurochemical and anatomical changes 
parallel the development of PFC dependent cognitive tasks in human infants 
(Diamond and Doar, 1989).  During this same period, longitudinal EEG studies of 
human infants show an increase in frontal electrical activity correlating with 
increasing proficiency at the performance of PFC dependent cognitive tasks (Bell and 
Fox, 1992). Toxin-exposure that occurs during this period may therefore have more 
marked effects on dorsolateral PFC dependent functions such as attention because it is 
during this period that the system undergoes critical developmental changes.  For 
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example, the late development of the PFC relative to other brain regions may make 
this system particularly sensitive to insult caused by exposure to environmental lead 
(Pb) during post-natal development, the time of maximal Pb-exposure due to increases 
in hand-to-mouth behavior (Bellinger, et al, 1994). 
 
Modulation by multiple neurotransmitter systems  
The PFC receives diffuse ascending projections from the main sources of the 
forebrain monoaminergic and cholinergic neurotransmitter systems. Noradrenergic 
afferents from the locus coeruleus (LC) project to PFC (Porrino, et al, 1982; Gatter, et 
al, 1977). Norepinephrine (NE) concentration and turnover is highest in PFC relative 
to other cortical areas (Brown, et al, 1977; 1979), and the coeruleocortical 
noradrenergic projection plays a critical role in the modulation of attentional 
regulation, as discussed below. The PFC receives dopaminergic innervation from the 
ventral tegmental area (A10), the retrorubral area (A8), and the medial third of the 
substantia nigra (A9) (Williams and Goldman-Rakic, 1998).   Like NE, DA levels in 
PFC are the highest of any cortical region (Brown, et al, 1977; 1979), and 
dopaminergic activity is critical to prefrontal control of executive functions such as 
attention, as discussed below. The PFC also receives widespread innervation from 
basal forebrain cholinergic neurons, and there is a wealth of evidence for the role of 
this afferent system in facilitating sustained attention and selection of attentional 
targets, particularly under conditions of high attentional demand (Sarter, et al, 2001; 
2005). Serotonergic neurons from the dorsal raphe nucleus also project to the PFC 
(Porrino, et al, 1982; Gatter, et al, 1977). This modulatory system appears principally 
to mediate functions such as impulsivity and response inhibition (Robbins, 2005); 
however, some evidence suggests it may play a role in attentional processing under 
certain circumstances (Winstanley, et al, 2003). 
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Functional interactions occur among these monoaminergic and cholinergic 
systems, and conditions that selectively alter the neurochemistry of one or more of 
these systems during early development may result in long-lasting changes in the 
prefrontal control of attention. For example, cocaine binds to the DA, NE, and 
serotonin transporters, increasing concentrations of these neurotransmitters in the 
synapse; the CNS effects of cocaine are reported to be due principally to DA 
transporter binding (Meyer, 1993; Ritz, et al, 1987; 1990; reviewed in Harvey, 2004). 
Prenatal cocaine-induced attentional impairments may be related to specific and 
lasting changes in one or more of these monoaminergic systems. 
  
Greater dependence on precursor availability 
An additional potential reason for the particular susceptibility of the prefrontal 
attentional system is its comparatively greater dependence on precursor availability.  
The mesocortical dopaminergic neurons that mediate attentional function have higher 
basal firing rates and greater DA turnover than other brain DA systems (Tam, et al, 
1990). This property makes these neurons more susceptible to small reductions in 
precursor availability than neurons in other DA systems.  Thus, selective deficits in 
these DA dependent attentional functions could conceivably result from conditions 
that cause changes in precursor availability which are insufficiently great to alter other 
brain systems.  For example, this mechanism has been proposed for the specific 
attentional and executive deficits resulting from the moderate phenylalanine/tyrosine 
imbalance still demonstrated in children treated for PKU (Diamond, 2001). 
The reasons described above make attentional systems particularly vulnerable 
to insult caused by variety of disorders or toxic agents.  The experiments described in 
this volume examine attentional deficits caused by exposure to two specific 
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developmental insults, environmental Pb-exposure and prenatal cocaine exposure, and 
examine the role of catecholaminergic attentional systems in these dysfunctions. 
 
Evidence for disordered attention following Pb-exposure 
Pb-induced deficits have been reported in studies of sustained attention (Dudek 
and Merecz, 1997; Harvey, et al, 1988; Hunter et al, 1985; Minder et al, 1994, 
Needleman, et al, 1979; 1990; Walkowiak, et al, 1998), selective attention (Bellinger, 
et al, 1994; Minder, et al, 1994; Raab, et al, 1990), and concentration (Faust and 
Brown, 1987). (See chapter 2 for review.)  Interpretation of these studies are 
complicated by a variety of limitations including methodological constraints and 
sociodemographic confounding, highlighting the importance of animal model studies 
of Pb-exposure. Deficits in sustained attention have been identified in rats following 
developmental Pb-exposure (Morgan, et al, 2001; Stangle, et al, 2007). However, no 
previous animal model studies have specifically demonstrated effects of Pb on 
selective attention or the ability to withstand distraction, although these deficits were 
associated with Pb-exposure in several studies of human children (Bellinger et al, 
1994; Minder et al, 1994; Raab et al, 1990). In addition, the specific neural changes 
that underlie these attentional deficits have not been established. 
 
Evidence for disordered attention following prenatal cocaine exposure 
A number of studies suggest that prenatal cocaine exposure causes attentional 
impairments in children (Azuma and Chasnoff, 1993; Beckwith, et al, 1995; Karmel 
and Gardner, 1996; Leech, et al, 1999; Mayes, et al, 1998; Richardson, et al, 1996). 
(See chapters 3 and 4 for review.) Again, many of these studies are difficult to 
interpret due to confounding factors such as polydrug abuse and poor postnatal care, 
highlighting the importance of animal model studies of prenatal cocaine exposure. 
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Prenatal cocaine-induced deficits in both focused or sustained attention (Gendle, et al 
2003; Morgan, et al, 2002) and selective attention (Bushnell, et al, 2000; Gabriel and 
Taylor, 1998: Garavan, et al, 2000; Gendle, et al, 2004; Kosofsky and Wilkins, 1998; 
Romano and Harvey, 1996) have been reported in adult animals, long after the period 
of exposure. Again, the neural bases of these attentional dysfunctions are not well 
understood. 
 
Specific role of catecholamines in attention 
Considerable evidence implicates the coeruleocortical NE system in various 
aspects of normal attentional function (Arnsten, 1998; Arnsten and Li, 2005; Aston-
Jones, et al, 1999; Ramos and Arnsten, 2007; Robbins, 1997; 2002).  Lesions to 
ascending noradrenergic neurons in rats increase distractibility in maze tasks (Roberts, 
et al, 1976) and impair performance on tasks of visual attention, specifically under 
conditions of highest attentional demand such as unpredictable target stimulus onset 
and presentation of distractors (Carli, et al, 1983; Cole and Robbins, 1992). LC 
activity and cortical NE release have been demonstrated to reduce cortical signal–to-
noise ratio (reviewed in Aston-Jones, 1988; 1997; Foote, et al, 1980; 1983; Sara, et al, 
1988), and enhance cortical cue and delay related firing relative to spontaneous firing 
(Sawaguchi, et al, 1990). Activity of LC neuron was closely correlated with 
performance on visual focused attention tasks in monkeys (Aston-Jones, et al, 1999). 
At the lowest levels of LC activity, vigilance performance was poor (Rajkowski, et al, 
1998). Moderate levels of tonic LC firing were associated with LC phasic activity 
which was selectively activated by attentional target stimuli, but showed no activation 
or was inhibited by distractors.  This mode of LC activity corresponded with higher 
levels of task performance, suggesting that this phasic LC firing may facilitate focused 
and selective attention (Aston-Jones, et al, 1994). In contrast, high levels of tonic LC 
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activity decreased the phasic responses to target stimuli and correlated with poor task 
performance (Aston-Jones, et al, 1994). Thus, LC activity produces an inverted U-
shaped effect on attention, with low levels of firing resulting in insufficient arousal 
and attention, moderate levels of tonic firing increasing attentional task performance, 
and high levels of tonic activity of LC neurons impairing vigilance and selective 
attention. 
This relationship between LC activity and attentional performance is consistent 
with behavioral pharmacology studies of noradrenergic modulation of attention.  
Idazoxan (IDZ), an alpha-2 adrenergic antagonist, increases firing of the LC and thus 
increases coeruleocortical NE activity (Aghajanian, et al, 1977; Dennis, et al, 1987). 
Administration of this drug to rats prior to performance of a visual selective attention 
task specifically altered distractibility as a function of baseline performance (Bunsey 
and Strupp, 1995); more distractible subjects showed IDZ-induced performance 
improvements, while less distractible subjects were impaired by IDZ.  This finding 
supports the above-stated hypothesis that coeruleocortical activity and endogenous NE 
release modulate attention according to an inverted U-shaped curve, in which an 
optimal level of NE facilitates attentional performance and both sub-optimal and 
supra-optimal levels produce relative impairments. This attentional effect is postulated 
to be mediated in part by prefrontal alpha-2 adrenergic receptors (Arnsten, 1998; 
Ramos and Arnsten, 2007), the receptors for which NE has the highest affinity 
(O’Rourke, et al, 1994). Alpha-2 receptors in PFC are localized both pre- and post-
synaptically (Aoki, et al, 1994; Aoki, et al, 1998; Venkatesan, et al, 1996); presynaptic 
alpha-2 receptors mediate the NE-mediated negative feedback of the LC, whereas 
postsynaptic alpha-2 receptors are implicated in the NE modulation of prefrontal 
functions (Arnsten, 1998; Arnsten and Li, 2005; Ramos and Arnsten, 2007). Thus, 
alpha-2 selective agents may either increase or decrease attentional task performance 
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in subjects, depending on both the subjects’ levels of endogenous NE activity and the 
dose-related ratio of binding to presynaptic vs. postsynaptic receptors.  Consistent with 
this hypothesis, alpha-2 adrenergic agonists have been shown to increase delay-related 
neuronal activity (Li, et al, 1999) and decrease distractibility during performance of 
working memory tasks in aged monkeys (Arnsten and Contant, 1992), to impair 
performance on visual attention tasks in rats (Sirvio, et al, 1994), to impair attention 
on the CPT (Coull, et al, 1995) and on visual target detection tasks of selective 
attention (Coull, et al, 2004; Smith and Nutt, 1996) in healthy human volunteers, 
improve CPT performance in patients with schizotypal disorder (McClure, et al, 
2007), and improve performance on the Stroop task in patients with Korsakoff’s 
amnesia, relative to the patient’s level of NE loss (Mair and McEntree, 1986).  
Guanfacine, an alpha-2 adrenergic agonist used in the treatment of ADHD, normalizes 
sustained attention in a rat model of ADHD (Sagvolden, 2006), impairs sustained 
attention in rats with lesions of the NE projections to PFC (Milstein, et al, 2007), and 
improves ADHD patient performance on both standard ADHD symptom rating scales 
(Hunt, et al, 1995; Scahill, et al, 2001; Taylor and Russo, 2001) and on more specific 
tests of attention such as the CPT (Scahill, et al, 2001) and the Stroop task (Taylor and 
Russo, 2001). Alpha-2 antagonists have been reported to decrease delay-related 
neuronal activity in monkeys (Li, et al, 1999), to narrow the focus of selective visuo-
spatial attention in human subjects (Smith, et al, 1992), and to improve accuracy in 
performance of a visual attention task in rats at low drug doses when signal brightness 
was reduced, but to impair performance at higher drug doses when target stimulus 
onset was unpredictable (Sirvio, et al, 1993; 1994). 
 NE has a lower affinity for the alpha-1 adrenergic receptor subtype (Mohell, et 
al, 1983), which also appears to play a role in the NE modulation of attention.  
Activity at this receptor subtype has been demonstrated to impair PFC dependant 
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cognitive functions in monkeys (Arnsten, et al, 1999; Mao, et al, 1999), although this 
evidence comes from tasks of working memory rather than attention.  In contrast, a 
study of the effects of the alpha-1 agonist ST-587 during the performance of a visual 
attention task in rats demonstrated a reduction in premature responses and an increase 
in accuracy under conditions of highest attentional demand (short cue duration) 
associated with the lowest drug dose, but not at higher doses.  Low doses of the alpha-
1 antagonist prazosin failed to alter task performance alone, but blocked the accuracy 
enhancing effects of the agonist; a higher dose of prazosin caused an impairment in 
accuracy on this task. (Puumala, et al, 1997)  These data suggest that NE activity at the 
alpha-1 receptor may also demonstrate a similar inverted-U shaped relationship with 
attentional performance. 
Extensive evidence also links dopaminergic activity to PFC dependent 
cognitive functions (reviewed in Arnsten, 1998; Arnsten and Li, 2005; Chudasama 
and Robbins, 2006; Robbins, 2000; 2005; Robbins and Roberts, 2007). Although the 
majority of the evidence for this DA modulation of prefrontal function is from studies 
of working memory, a number of studies do provide support for a role for DA in 
attentional function. Extracellular PFC DA was elevated during performance of a task 
of visual attention in rats (Dalley, et al, 2002), and DOPAC/DA ratios in right frontal 
cortex were significantly correlated with accuracy on another variant of the same task 
(Puumala and Sirvio 1998). Systemic administration of the selective D1 antagonist 
SCH23390 impaired accuracy and increased errors of omission on this same task 
(Passetti, et al, 2003). Depletion of PFC DA increased distractibility and facilitated 
attentional set-shifting in marmosets, likely due to an impairment of attentional set 
acquisition (Crofts, et al, 2001). Treatment of rats with tolcapone, a catachol-o-
methyl transferase inhibitor which has been shown to elevate stimulated prefrontal 
DA but not NE release, enhanced attentional set shifting in rats (Tunbridge, et al, 
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2004).  Intra-PFC infusions of a variety of DA receptor subtype specific agonists and 
antagonists also altered attentional set shifting performance in the rat (Floresco, et al, 
2006; Ragozzino, 2002). Treatment with the DA D2 receptor antagonist sulpiride 
induced deficits in attentional set shifting in healthy human volunteers (Mehta, et al, 
1999). Similarly, the DA insufficiency demonstrated by unmedicated Parkinson’s 
patients was associated with deficits in extra-dimensional set-shifting ability which 
were ameliorated by treatment with l-dopa medication (Downes, et al., 1989) and 
recurred with l-dopa withdrawal (Cools, et al, 2001).  
Like NE, dopaminergic modulation of attentional function also appears to 
follow an inverted-U shaped curve. Electrophysiological and behavioral 
pharmacological studies have established that moderate DA activity in PFC is 
commensurate with optimal functioning of this brain region, whereas both suboptimal 
(Sawaguchi, et al, 1988; 1994) and supraoptimal (Murphy, et al., 1996; Wang, et al, 
2004; Zahrt, et al., 1997) DA activity impairs PFC-dependent functions. This effect 
appears to be modulated principally by DA activity at the D1 DA receptor subtype, 
the predominant DA receptor subtype in PFC (Lidow, et al, 1991). Although the 
majority of the evidence for this DA modulation of prefrontal function is from studies 
of working memory, there is some evidence that this inverted U-shaped relationship 
also exists between PFC DA activity and attentional function.  Prefrontal 
microinfusions of the DA D1 receptor partial agonist SKF38393 prior to performance 
of a visual attention task selectively improved accuracy in rats with low baseline 
levels of performance, whereas microinfusions of the DA D1 antagonist SCH23390 
selectively impaired accuracy in rats with high baseline levels of performance. 
(Granon, et al, 2000).  This finding was consistent with the attentional enhancement 
produced by prefrontal microinfusions of two doses of the selective full D1 agonist 
SKF81297 in rats performing a task containing both sustained attention and working 
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memory components (Chudasama and Robbins, 2004).  Notably, although two drug 
doses produced enhancement of attention, the highest dose also altered accuracy on 
the memory component of the task as a function of baseline performance; this dose 
impaired performance at the short delay and improved performance at the long delay. 
This finding suggests that although prefrontal DA activity regulates both working 
memory and attention by an inverted U-shaped function, optimal DA levels for 
regulating these two cognitive functions may differ. Additional studies suggest that 
D2 and D4 DA receptor specific agents may also alter attention as a function of 
baseline performance. Intra-PFC microinfusions of a selective D4 agonist impaired 
performance on an attentional set-shifting test in the rat, while microinfusions of a D4 
selective antagonist improved set-shifting (Floresco, et al, 2006). Systemic treatment 
with the DA D2 receptor antagonist sulpiride impaired response accuracy on a task of 
visual attention in normal rats (Harrison, et al, 1997), but ameliorated accuracy 
deficits in rats with lesions to PFC (Passetti, et al, 2003). As prefrontal 
microinfusions of sulpiride in normal rats had no effect on response accuracy in this 
task (Granon, et al, 2000), the authors hypothesized that the drug’s attention 
impairing effects in normal rats were due to blockade of D2 receptors in striatum, 
while the attentional enhancements in the PFC lesioned rats resulted from an 
attenuation of striatal dopaminergic hyperactivity induced by the PFC lesions. 
 
Effects of Pb- exposure on noradrenergic systems 
The critical role described above of the coeruleocortical noradrenergic system 
in the modulation of attention makes this system a plausible cause of the attentional 
deficits induced by environmental Pb-exposure.  Unfortunately, studies of effects of 
Pb-exposure on NE function report disparate results, likely due to the numerous 
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methodological differences across studies. (See chapter 2 for review.)  Previous 
studies have been inconsistent with regard to both the presence and direction of Pb 
effects on various measures of NE function. However, a number of groups have 
reported Pb-induced increases in measures of NE in forebrain (Rossouw, et al, 1987; 
Silbergeld and Goldberg, 1975) and frontal, parietal, and occipital cortex (Freedman, 
et al, 1990). In addition, Pb-induced increases and decreases in measures of NE 
function have been reported in midbrain (Dubas, et al, 1978; McIntosh, et al, 1989), 
cortex (Devi, et al, 2005; Prasanthi, et al, 2005; Rajanna, et al, 1997; Rossouw, et al, 
1987), hippocampus ( Devi, et al, 2005; Collins, et al, 1984; Kumar and Desiraju, 
1990; Prasanthi, et al, 2005), and striatum (Dubas, et al, 1978; Jason and Kellogg, 
1981; Kumar and Desiraju, 1990). Prior studies have also observed alterations in 
sensitivity to the effects of NE drugs (Carter and Leander, 1980; Grover, et al, 1993; 
Rafales, et al, 1981; Reiter, et al, 1975). These studies have not assessed the specific 
functional consequences of the noradrenergic alterations.  
 
Effects of Prenatal Cocaine Exposure on Catecholaminergic systems 
Alterations in these underlying catecholaminergic systems may also mediate 
the attentional impairments induced by prenatal cocaine exposure.  The available 
evidence concerning effects of prenatal cocaine exposure on central catecholaminergic 
activity is also inconsistent, due to the wide variation in both doses of cocaine and 
routes of administration. (See Chapters 3 and 4 for review) However, evidence from 
studies utilizing low dose IV exposure regimens that closely mimic recreational 
cocaine use in humans present a more consistent picture of the effects of prenatal 
cocaine exposure on catecholaminergic function. IV prenatal cocaine exposure has 
been reported to alter noradrenergic receptor number (Booze, et al, 1994; 2006; 
Elsworth, et al, 2007), inhibit the outgrowth of neurites in LC neurons (Snow, et al, 
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2001), and cause changes in measures reflecting NE levels and NE turnover (Booze, 
2006; Wang, et al 1996, Elsworth, et al, 2007), including stress induced NE turnover 
in PFC and down-regulation of LC autoreceptors (Elsworth, et al, 2007).  Studies of 
IV prenatal cocaine exposure have also demonstrated prenatal cocaine-induced 
decreases in regional D1 receptor G-protein coupling (Friedman, et al, 1996; Levitt, et 
al, 1997; Wang, et al, 1995) and increases in the amount of DA released in response to 
a stressor or a pharmacological challenge, but not alterations in basal DA levels or 
release (Du, et al, 1999; Elsworth, et al, l999; Morrow, 2001; Wang, et al, 1995; 
1996), or DA D1 receptor number (DeBartolomeis, 1994; Leslie, et al, 1994). Again, 
however, these studies have not assessed the specific cognitive/behavioral 
consequences of the catecholaminergic alterations. 
 
Linking neurochemistry/pharmacology with function 
Pb-exposure and prenatal cocaine exposure both cause deficits in attentional 
function and have been demonstrated to cause alterations in measures of 
catecholaminergic activity.  However, prior to the studies described in the current 
volume, there was no evidence to directly link these toxin- or drug-induced 
catecholaminergic changes to the exposure-induced deficits in attention. The studies 
described in this volume examine the functional significance of these 
catecholaminergic changes.  These studies use pharmacological challenges to test the 
hypothesis that the alterations in attentional function caused by environmental Pb-
exposure and prenatal cocaine exposure are due to alterations in the catecholaminergic 
neurochemical systems underlying attention.  In these studies, exposed and control 
subjects were administered a range of doses of specific catecholaminergic drugs, and 
tested on an attentional task requiring subjects to monitor an unpredictable light cue in 
the presence of olfactory distractors.  Dose-effect curves were generated for each 
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subject, and curves for exposed and control subjects were compared.  A shifting of the 
dose-effect curves in exposed subjects relative to controls was the critical measure 
used to indicate altered sensitivity to the effects of the catecholaminergic drug on 
attentional task performance in the exposed subjects, and to provide evidence for 
exposure-induced changes in the catecholaminergic systems mediating attentional 
function. Chapter 2 examines the nature of the attentional dysfunction induced by 
environmental (Pb)-exposure and the role of noradrenergic activity in these Pb-
induced attentional impairments, using a challenge with the alpha-2 noradrenergic 
antagonist idazoxan.  Chapters 3 and 4 examine the roles of noradrenergic and 
dopaminergic systems in prenatal cocaine-induced attentional dysfunctions, using 
idazoxan and the selective DA D1 receptor agonist SKF81297 respectively. It is 
critical to identify the specific neurochemical changes that underlie these attentional 
deficits in order to develop drug therapies that may ameliorate the dysfunction. 
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CHAPTER 2 
 
CHRONIC POST-WEANING LEAD-EXPOSURE IMPAIRS ATTENTION 
BUT DOES NOT ALTER SENSITIVITY TO THE EFFECTS OF IDAZOXAN 
ON DISTRACTION TASK PERFORMANCE 
 
ABSTRACT 
 
The present two studies were conducted to examine the effects of lead (Pb)-
exposure on sustained and selective attention and to test the involvement of 
noradrenergic (NE) systems in Pb-induced attentional dysfunction.  In study 1, Pb-
exposed and control rats were tested on a distraction task which assessed the ability of 
the subjects to monitor an unpredictable light cue and maintain performance when 
presented with olfactory distractors.  Pb-exposed subjects exhibited impaired accuracy 
on this task relative to controls.  In study 2, Pb-exposed and control rats were 
administered the alpha-2 adrenergic antagonist idazoxan  (IDZ:  0, 0.5, 1.0, 1.5 mg/kg) 
and tested on a version of the same distraction task. Analyses revealed specific 
attentional effects of IDZ: The highest dose of the drug (1.5 mg/kg) improved 
accuracy, specifically in the most attentionally demanding conditions; i.e., trials with 
either the briefest light cue or those in which an olfactory distractor was presented.  
The specificity of the drug effects rules out nonspecific alterations in performance as 
the basis of IDZ effects.  Furthermore, the analyses did not reveal a differential effect 
of IDZ in Pb-exposed and control rats. These results provide evidence for Pb-induced 
impairments in sustained or focused attention, but fail to support the hypothesis that 
alterations in the coeruleocortical NE pathway contribute to this Pb-induced 
attentional dysfunction.  
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INTRODUCTION 
 
Recent recalls of lead-contaminated children’s toys and other consumer 
products demonstrate that environmental lead (Pb) contamination continues to pose a 
serious health risk.  Attentional impairments, such as the deficits in sustained and 
selective attention commonly associated with attention deficit hyperactivity disorder 
(ADHD), are frequently cited as a consequence of exposure to Pb in children. 
However, much of this evidence for Pb-induced attentional dysfunction comes from 
studies which report correlations between Pb exposure levels and parent/teacher 
behavior ratings (Baloh et al, 1975; Benetou-Marantidou et al, 1988; Fergusson, et al, 
1988; Needleman et al, 1979; Silva, et al, 1988; Thomson, et al, 1989; Tuthill, 1996; 
Yule, et al, 1984). These studies are difficult to interpret due to both their lack of 
specific information on the cognitive processes altered by Pb and the presence of 
confounding sociodemographic factors. 
The relatively few studies that have specifically examined attentional processes 
in children have yielded inconsistent results. Mixed results have been reported for both 
simple and choice reaction time tasks; sustained and selective attentions contribute to 
performance on these tasks respectively.  Some studies have observed an association 
between lead exposure and simple (Dudek and Merecz, 1997; Hunter et al, 1985; 
Minder, et al, 1994, Needleman, et al, 1979) or choice reaction time (Minder, et al, 
1994; Raab, et al, 1990), while other studies have found no Pb-associated deficits in 
simple (Winneke, et al, 1990, 1994) or choice reaction time (Dudek and Merecz, 1997; 
Winneke, et al, 1989; 1990).  Inconsistent results have also been reported for the 
Continuous Performance Test (CPT), a task that reveals deficits in children with 
ADHD. One study observed an association between Pb exposure and performance on 
this task (Walkowiak, et al, 1998); while two earlier studies found no association 
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between Pb-exposure and any measure of performance (Hansen, et al, 1989; Harvey, 
et al, 1988).  A fourth study failed to find an association between Pb-exposure and 
overall task performance, but did report a significant association between Pb-exposure 
and the ability to “focus-execute”, which the authors interpret as an index of selective 
attention (the ability to select and respond to critical information) (Bellinger, et al, 
1994). Faust and Brown (1987) reported a borderline effect of early Pb-exposure on 
the subdivision of concentration but no effect on the subdivision of attention in a 
neuropsychological test battery.  Finally, Padich et al (1985) found no association 
between Pb-exposure in 18-month old infants and attentional measures in a structured 
problem-solving task. 
The inconsistent results reported above likely reflect a variety of factors 
including timing of Pb-exposure, whether complete longitudinal information 
concerning lifetime lead exposure was available, the sensitivity of the testing 
instrument in detecting subtle effects, and the range of lead exposures in the study 
population. In addition, these inconsistencies may also be due to variation in the extent 
to which lead exposure in these studies is confounded with sociodemographic 
variables associated with cognitive development such as quality of the home 
environment, as well as the methods used to assess and statistically control for these 
factors. (For detailed discussion of this issue, see Morgan, et al, 2001). 
Due to these limitations, it is important to assess the putative effect of lead on 
attention using animal models, where lead exposure can be studied in the absence of 
these sociodemographic factors which tend to co-occur with lead in the human 
situation and which themselves are risk factors for impaired cognitive functioning. 
Two studies have found simple reaction time unimpaired in Pb-exposed monkeys, 
(Rice, 1988, Hopper, et al, 1986); however, in both of these studies the cue was 
presented immediately after trial onset, limiting the demands the task placed on 
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attention. Two studies of reversal tasks with irrelevant cues reported systematic 
responding to the irrelevant cues by Pb- exposed monkeys, which the authors 
interpreted as impairments in selective attention (Rice, 1992; Rice and Gilbert, 1990).  
However, these findings can also be explained as a Pb-induced associative deficit (see 
Garavan, et al, 2000; Hilson and Strupp, 1997). Studies from our laboratory have 
identified deficits in sustained attention in rats following both developmental (Morgan, 
et al, 2001; Stangle, et al, 2007) and chronic post-weaning (Driscoll, 2003) Pb-
exposure.  However, whether these effects extend to selective attention is still unclear, 
although selective attention deficits were associated with Pb-exposure in several 
studies of children (Bellinger, et al, 1994; Minder, et al, 1994; Raab, et al, 1990). 
Clearly, additional animal-model studies are needed to assess the specific nature of the 
attentional functions that are altered following exposure to Pb. 
In addition to identifying the nature of the attentional dysfunction induced by 
Pb-exposure, identification of the neurochemical basis of these observed attentional 
deficits is necessary for the development of therapeutic intervention strategies.  The 
locus coeruleus (LC) is essential for various aspects of normal attentional processing, 
including selective and focused attention (see Bunsey and Strupp, 1995 for review; 
Arnsten, et al, 1992; 1996; 1997; 2005; Aston-Jones, 1988; 1997; 1999; Bushnell, 
1998; Clark, et al, 1987a, 1987b; Ramos and Arnsten, 2007; Robbins, 1997; Sara, 
1985; Sara, et al, 1988) and scanning attentiveness (Aston-Jones, 1999), suggesting 
alterations in the coeruleocortical noradrenergic (NE) neurotransmitter system as a 
good candidate for the basis of  Pb-induced attentional impairments.  However, the 
available evidence concerning effects of Pb-exposure on NE function is inconsistent.  
Previous studies have been inconsistent with regard to both the presence and direction 
of Pb effects on various measures of NE function including levels of NE in urine 
(Payton, et al, 1993; Tang, et al, 1995), plasma (Carmignani, 2000; Chang, et al, 
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1996a; 1996b; Goldman, et al, 1980), and whole brain (Flora, et al, 2007; Golter and 
Michaelson, 1974; Rafales, et al, 1981; Sauerhoff and Michaelson, 1973; Saxena and 
Flora, 2006; Tandon, et al, 1984) and regional NE levels (Bailey and Kitchen, 1986; 
Baksi and Hughes, 1982; Collins, et al, 1984; Devi, et al , 2005; Dubas, et al, 1978; 
Freedman, et al, 1990; Grant, et al, 1976; Hrdina, et al, 1976; Jason and Kellogg, 
1977; 1981; Kumar and Desiraju, 1990; McIntosh, et al, 1988; 1989; Meredith, et al, 
1988; Prasanthi, et al, 2005; Silbergeld and Goldberg, 1975; Sobotka and Cook, 1974; 
Sobotka, et al, 1975; reviewed in Moore, et al, 1986); levels of VMA in urine 
(Silbergeld and Chisolm, 1976; Silbergeld and Goldberg, 1975; Tang, et al, 1995) and 
brain (Silbergeld and Chisolm, 1976); adrenergic receptor number (Rajanna, et al, 
1997; Chang, et al, 1996a; Roussouw, et al, 1987)  and affinity (Roussouw, et al, 
1987); NE turnover (Collins, et al 1984; Goldman, et al, 1980; Michaelson, et al, 
1974); NE uptake (Agrawal, et al, 1986; Silbergeld and Goldberg, 1975); tyrosine 
hydroxylase levels (McIntosh, et al, 1988; 1989; Meredith, et al,  1988; Schumann, et 
al, 1977; Wince and Azarro, 1978; reviewed in Moore, et al, 1986); regional NE 
terminal density (Freedman, et al, 1990); in vitro NE release (Tomsig, et al, 1993); NE 
induced inosital incorporation (Rajanna, et al, 1997); and behavioral response to NE 
drug challenge (Carter and Leander, 1980; Fregoneze, et al, 1997; Grover, et al, 1993; 
Rafales, et al, 1981; Reiter, et al, 1975). Differences in exposure period, age at testing, 
lead level, and brain region tested make comparisons across studies difficult to draw, 
and may be the likely basis for the disparity in findings.  Moreover, these studies have 
not assessed the specific functional consequences of these alterations.  
The current series of investigations were designed to shed additional light on 
both the nature and the basis of Pb-induced deficits in attention.  Experiment 1 was 
designed to ascertain the effects of chronic post-weaning lead exposure on both 
sustained and selective attention, using a visual attention task in which olfactory 
 37 
distractors were presented unpredictably on some trials.  Experiment 2 used a 
pharmacological challenge design to test the hypothesis that alterations in the NE 
system contribute to Pb-induced attentional deficits.  
 
EXPERIMENT 1 
 
MATERIALS AND METHODS 
Subjects 
Female Long-Evans rats were obtained from Harlan Sprague-Dawley on 
postnatal day (PND) 21.  Rats were housed in pairs or triples in hanging wire mesh 
cages.  The room in which subjects were both housed and tested was maintained on a 
reversed dark/light cycle. (Lights on: 2100; lights off: 0730) 
 On PND25, subjects were randomly assigned to one of three Pb treatment 
conditions stratified for weight, food intake, and water intake.  These three conditions 
corresponded to the concentration of Pb acetate in the drinking water. (1) High Pb 
(n=14):  Subjects’ water contained 250 ppm Pb acetate. (2) Low Pb (n=13): Subjects’ 
water contained 50 ppm Pb acetate. (3) Control (n=15):  Subjects’ water contained 
250-ppm sodium acetate instead of Pb acetate.  Subsequent analysis of water revealed 
unexpectedly low Pb concentrations, particularly in the 50ppm Pb acetate condition. 
Consequently, in order to produce the desired Pb level, starting at PND132 Pb acetate 
was dissolved in MilliQ water (Millipore, Bedford, MA) and concentrations were 
increased to 75 ppm and 300 ppm for the low and high Pb group respectively.  The 
control group received 300-ppm sodium acetate dissolved in MilliQ water (Millipore, 
Bedford, MA). Drinking water was available ad libitum. Research in this lab has 
demonstrated that these regimens do not result in differential water intake. (Saelens 
and Strupp, unpublished data). Rats were maintained on these treatments throughout 
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behavioral testing.  Subjects were maintained on a semipurified diet (AIN76, US 
Biochemicals Corp) to maximize lead absorption.  
 
Blood lead analyses 
Following completion of behavioral testing, a blood sample was taken from 
each subject via tail-nick. Blood lead (BPb) concentration assays were performed by 
the Wisconsin State Hygiene Laboratory (WSHL) using graphite furnace atomic 
absorption spectrophotometry.  The WSHL, in cooperation with the Centers for 
Disease Control and the Bureau of Maternal and Child Health, administers the 
Nationwide Blood Lead Proficiency Testing Program. 
 
Apparatus 
Testing was conducted in 11 automated Plexiglas chambers enclosed in sound-
attenuating wooden boxes, each operated by a Commodore 128 computer.  Each 
chamber consisted of a square waiting area (26.5 cm by 25 cm by 30 cm), adjacent to 
a testing alcove containing 3 funnel-shaped ports.  An LED was mounted above each 
port.  These 2 compartments were separated by a thin metal door, which was raised to 
initiate each trial. The left and right ports were at an approximate 45-degree angle 
relative to the center port and the distance between the left and right ports was 8 cm.  
Each port was connected by tubing to three bottles containing liquid odorants, attached 
to a board placed outside of the box   Solenoid valves controlled the presentation of 
compressed air, pumped through a specific odorant and through a specific port.   The 
airflow rate was 1.0 L/min and the air in the chamber was cleared via small centrifugal 
fans mounted on the outside of the chambers, at a rate of four complete exchanges per 
minute.  A set of infrared phototransistors and a light source monitored the entrance to 
the alcove and each port.  A nose-poke of ≥ 1 sec into one of the three ports 
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constituted a response.  Correct responses were reinforced with a 45 mg food pellet 
(Noyes, Lancaster, NH) delivered into the alcove from a pellet dispenser (Lafayette 
Instrument Co., Lafayette, IN). 
 
Prior behavioral testing 
 Training/behavioral testing began for all subjects on PND171. During 
behavioral testing, subjects were maintained on a restricted feeding regimen: 4 hours 
ad lib access daily, immediately following behavioral testing. Subjects were trained on 
several attentional tasks as part of a previous experiment (Strupp, et al, 1993): 1) a 
three-choice visual discrimination task in which the correct port was designated by the 
illumination of an LED mounted over that port immediately after trial onset; and 2) a 
vigilance task in which the interval between trial onset and cue illumination varied. 
 
Distraction Task 
Daily sessions consisted of 100 trials or 90 minutes, whichever came first.  The 
opening of the alcove door signaled the onset of each trial.  After the subject entered 
the testing alcove, one of the three LEDs was illuminated for 1 sec duration. Two 
parameters were randomly varied across the trials in the session for all subjects:  1) 
pre-stimulus delay (2 or 3 sec after alcove entry); and 2) presentation and timing of 
distractors:  On 2/3 of the trials in each session, one of nine different odors was 
delivered through one of the three ports, either one second (“-1 distractor condition”) 
or two seconds (“-2 distractor condition”) prior to visual cue onset.  No odors were 
presented on the remaining one third of the daily trials (nondistraction trials).  The 
delay, cue location, and distraction condition for each trial were selected 
pseudorandomly, balanced for each session. A 1-sec nose-poke into the port under the 
illuminated light was deemed correct, resulted in the delivery of a reinforcement, and 
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ended the trial, signaled by the closing of the alcove door.  A nose-poke of ≥ 1 sec into 
any port prior to the light cue onset (premature response) or into an incorrect port 
following the cue ended the trial with no reinforcement.  If the animal failed to enter 
the alcove within 60 sec or failed to respond within 60 sec of light cue offset, the 
alcove door closed and a nontrial was recorded.  Nontrials did not count towards the 
maximum 100 trials per day, nor were they averaged into the calculation of percentage 
correct for that session.  An inter-trial interval of 15 sec was imposed between 
successive trials. Subjects received 14 days of testing on this task.   
Behavioral testing was conducted by personnel who were blind to treatment 
condition of the rats. 
 
Statistical Analysis 
 Behavioral data were analyzed with a mixed models analysis of variance 
procedure using the SAS version 6.11 PROC MIXED on Cornell’s mainframe 
computer. Percentage correct was calculated for each session and analyzed as a 
function of lead treatment (termed Pb), day, pre-stimulus delay, distraction condition, 
and the relevant interactions of these variables.   Nontrials and premature responses 
were analyzed as a function of Pb treatment, day, and the interaction of these 
variables. 
 
RESULTS 
 
Body weight 
The body weights of the three treatment groups did not differ significantly 
(F=1.47, p=0.48).  Mean body weights prior to start of the distraction task were 266, 
275, and 286 g for the control, low, and high Pb groups respectively. 
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Blood lead levels 
Median blood Pb (BPb) levels were <5 µg/dl, 19 µg/dl, and 39 µg/dl for the 
control, low, and high Pb groups respectively.  Results of a subsequent study 
comparing the accuracy of  BPb sampling techniques indicated that tail-nick blood 
samples such as these tend to overestimate BPb levels (See Morgan, et al, 2000). 
Thus, it is likely that true BPb values for these subjects were lower than reported. 
 
Percentage Correct 
Percentage correct for a given session was calculated as number of trials on 
which a correct response was made divided by the total number of response trials in a 
session, multiplied by 100.  Response trials were defined as those trials on which the 
animal entered the testing alcove and made a response within 60 seconds.  There was a 
main effect of Pb treatment on percent correct [F (2,39)=8.07, p=0.0012) reflecting the 
fact that percent correct was lower, relative to controls, in both the high (p=0.0151) 
and low (p=0.0003) Pb treatment groups (See figure 2.1) There was a significant 
overall effect of distraction condition on percent correct [F (2,2787)=248.86, 
p=0.0001], reflecting the fact that there was a significant reduction in percent correct 
under both distraction conditions relative to the nondistraction condition, the “-1” 
distraction condition in which distractors were presented 1 second before light cue 
presentation [p=0.0001] and the “-2” distraction condition [p=0.0001] in which 
distractors were presented 2 seconds before light cue presentation.  In addition, 
percent correct was significantly lower under the “-2” distraction condition relative to 
the “-1” distractor condition [p=0.0001].  There was a borderline interaction of Pb 
treatment and distraction condition [F (4,2787)=2.45, p=0.0577]. However, this 
borderline interaction did not reflect greater group differences under the distraction 
conditions relative to the nondistraction condition (which would indicate greater 
 42 
distractibility in the lead-exposed animals).  Both Pb-exposed groups were similarly 
impaired relative to the control group in all three conditions (i.e., the nondistraction 
condition and the two distraction conditions), as depicted in Figure 2.2.   
Percent correct increased across days of testing [F (13,497)=14.45, p=0.0001] 
reflecting an increase in performance in the distraction conditions.  The interaction of 
Pb treatment and day [F (26, 497)=0.95, p=0.53] was not significant, nor was the 
interaction of Pb treatment, day, and distraction condition [F (52,2787)=0.97, p=0.55].  
 
Figure 2.1. Pb treatment significantly reduced percent correct (p=0.0012), reflecting 
the fact that percent correct was lower relative to controls in both the high (p=0.0151) 
and low (p=0.0003) Pb treatment groups.  This reduction in percent correct reflected 
Pb-induced decreases in accuracy.  
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Figure 2.2. Both Pb-exposed groups were similarly impaired relative to the control 
group during all three distraction conditions: the nondistraction trials [low vs. control: 
p=0.0004; high vs. control: p=0.01], the “-1” distractor condition [low vs. control: 
p=0.0001; high vs. control: p=0.003], and the “2” distractor condition [low vs. control: 
p=0.0001; high vs. control: p=0.03]. 
 
Premature Responses 
Premature responses for a given session were calculated as those trials in the 
session on which the subject made a >1 sec nosepoke to any port prior to light cue 
presentation. This type of response terminated the trial and was considered an index of 
impulsivity and/or deficient response inhibition. The rate of premature responses was 
not significantly altered by Pb treatment [F (2, 39)=0.85, p=0.44], testing day [F (13, 
491)=1.47, p=0.13], or the interaction of these variables [F (26, 491)=0.96, p=0.53].   
Mean percent premature responses were 10.7±2.3, 15.2±2.5, and 12.7±2.4 for the 
control, low Pb, and high Pb treatment groups respectively. 
 
 44 
 
Nontrials 
Nontrials for a given session were calculated as those trials in the session on 
which the subject either failed to enter the testing alcove within 60 seconds, or entered 
the alcove but failed to make a response within 60 seconds. The rate of nontrials was 
not significantly altered by Pb treatment [F (2, 39)=1.15, p=0.33], testing day [F (13, 
494)=1.03, p=0.42], or the interaction of these variables [F (26, 494)=1.01, p=0.46]. 
Mean nontrials were 6.9±2.0, 7.1±2.1, and 10.8±2.1 for the control, low Pb, and high 
Pb treatment groups respectively. 
 
EXPERIMENT 2 
 
As discussed in the Introduction, Experiment 2 was designed to test the 
hypothesis that alterations in the NE system contribute to Pb induced attentional 
dysfunction. Rats exposed to Pb and control rats were administered a range of doses of 
idazoxan (IDZ), an alpha-2 adrenergic antagonist that increases NE release from LC 
projections (Aghajanian, et al, 1977; Dennis, et al, 1987), prior to testing on a variant 
of the distraction task used in study one.  IDZ dose-effect curves for Pb-exposed and 
control subjects were compared; altered sensitivity to the attentional effects of IDZ in 
Pb-exposed subjects was considered indicative of alterations in the NE system 
underlying attention. 
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MATERIALS AND METHODS 
 
Subjects 
Female Long-Evans rats were obtained from Harlan Sprague-Dawley on 
postnatal day (PND) 21.  Rats were housed in pairs or triples in hanging wire mesh 
cages.  The room in which subjects were both housed and tested was maintained on a 
reversed dark/light cycle. (Lights on: 2100; lights off: 0730) 
On PND25, subjects were randomly assigned to one of two lead treatment 
conditions, stratified for weight, food intake, and water intake. These conditions 
corresponded to the concentration of lead acetate in the drinking water. Pb exposed 
subjects (n=11) had ad lib access to MilliQ water (Millipore, Bedford, MA) 
adulterated with 300 ppm Pb acetate. The water of the control subjects (n=9) 
contained 300-ppm sodium acetate instead of Pb acetate. Drinking water was available 
ad libitum and rats were maintained on their respective treatment throughout 
behavioral testing. Subjects were maintained on a semipurified diet (AIN76, US 
Biochemicals Corp.) to maximize lead absorption. 
 
Blood lead analyses 
Following completion of behavioral testing, a blood sample was taken from 
each subject via tail-nick. Blood lead (BPb) concentration assays were performed by 
the Wisconsin State Hygiene Laboratory (WSHL) using graphite furnace atomic 
absorption spectrophotometry.  The WSHL, in cooperation with the Centers for 
Disease Control and the Bureau of Maternal and Child Health, administers the 
Nationwide Blood Lead Proficiency Testing Program. 
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Apparatus  
Testing was conducted in the same 11 automated Plexiglas chamber described 
in experiment one, each operated by a Commodore 128 or IBM PC XT computer.  
 
Prior Behavioral Testing 
Initial training/behavioral testing began for all subjects on PND 90. Subjects 
were trained on the same prior attentional tasks described in experiment 1, followed 
by 14 days of training on a variant of the distraction task described below. Prior to 
initiation of the IDZ challenge study, subjects received 12 additional days of testing on 
the distraction task to achieve a stable baseline performance level for each rat, then 
participated in a study designed to test the effects of the D1 dopamine agonist 
SKF81297 (Bayer, et al, 1994). 
 
Distraction Task 
This distraction task was identical to the task described for experiment 1, with 
the following exceptions:  1) The duration of illumination of the LED visual cue was 
randomly varied across subjects; half of the subjects in each treatment group were 
presented with a 500 msec cue and half were presented with a 1 sec cue.  2) Trials on 
which olfactory distractors were presented were reduced to 1/3 of daily trials. No 
odors were presented on the remaining two thirds of the daily trials. 
 
Idazoxan challenge study 
Subjects were maintained on a restricted feeding schedule to maintain adequate 
motivation.  Food weights were determined for each animal on an individual basis to 
identify the largest daily intake that would still maintain high response trials and low 
nontrials.  Daily sessions consisted of 100 trials or 90 minutes, whichever came first.  
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IDZ (0.0, 0.5, 1.0, 1.5 mg/ml/kg; Research Biochemicals, Inc, Natick MA) was 
dissolved in sterile MilliQ water (Millipore, Bedford, MA) immediately prior to each 
daily session and was administered subcutaneously 15 minutes prior to testing.  Each 
subject received each of the 4 doses 3 times (in three testing blocks), with dose order 
determined by a Latin Square design.  48 hrs were imposed between successive 
injection days to allow drug clearance.   
 
Response types   
Percentage correct, premature responses and nontrials were calculated for each 
session. Omission errors, in which the rat entered the testing alcove but failed to 
respond within 10 seconds, were calculated separately from nontrials in Experiment 2 
and counted toward the overall percent correct figure. This calculation of omission 
errors differed from that used in study 1, in which this response type was counted as a 
nontrial and did not count towards the overall percent correct figure. This change was 
made based on evidence that omission error rate reflects distinct cognitive processes 
from those tapped by nontrials (for discussion see Bayer, et al, 2000, 2002). In 
addition, as the Pb-induced impairments in Experiment 1 appeared related to treatment 
differences in accuracy, inaccurate responses were also calculated separately to 
provide a more in-depth analysis of this response type. 
 
 
Statistical Analysis 
Data were analyzed with a mixed models analysis of variance procedure using 
the SAS version 6.11 PROC MIXED on Cornell’s mainframe computer.  To achieve a 
more normal distribution, percentage error-type data were calculated across all three 
sessions of a given dose for each rat and arcsin square root transformed prior to 
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analysis. Percentage error-type data (percentage errors of omission, percentage 
accuracy errors, percentage premature responses) were analyzed as a function of lead 
treatment (termed Pb), IDZ dose (termed IDZ), pre-stimulus delay, light cue duration, 
distraction condition, and the relevant interactions of these variables.  Similar analyses 
were conducted on the percentage correct, although testing block was also included in 
these analyses. Nontrials were analyzed as a function of lead treatment, IDZ dose, and 
the relevant interactions of these variables.  
In all of these analyses, the critical test of differential sensitivity of the 
treatment groups to IDZ was an interaction of Pb treatment and IDZ dose. 
 
RESULTS 
Body weight 
The body weights of the two treatment groups did not differ significantly (T 
(20)=0.625, p=0.27).  Mean body weights on day one of the IDZ challenge study were 
325 and 331 g for the control and Pb-exposed groups respectively. 
 
Blood lead levels 
Median blood lead (BPb) levels were <5 µg/dl and 56 µg/dl for the control and 
Pb groups respectively.  The results of a subsequent study comparing the accuracy of 
several BPb sampling techniques indicated that tail-nick blood samples such as these 
tend to overestimate BPb levels (see Morgan, et al, 2000). Thus, it is likely that the 
true BPb values for these subjects were somewhat lower than reported. 
 
Percentage Correct 
Percentage correct for a given session was calculated as the percentage of trials 
in the session on which a correct response was made within 10 seconds of trial onset. 
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There was no effect of Pb treatment on overall percentage correct [Pb: F 
(1,1231)=0.32, p=0.57], nor was there an overall effect of IDZ on this measure [IDZ: 
F (3,1231)= 0.48, p=0.69]. This measure also did not reveal an interaction of Pb 
treatment and IDZ dose [Pb*IDZ: F (3,1231)=0.93, p=0.42].  Mean overall percentage 
correct was 84.69+2.40 and 82.85+2.20 for the control and Pb-exposed groups 
respectively.    
 
Inaccurate Responses 
Inaccurate responses (“timely” responses to the wrong port) were calculated 
for each condition as follows: The number of trials on which an incorrect port was 
chosen after light cue presentation but within 10 seconds of trial onset was divided by 
the total number of response trials in that condition.   A trend was seen for IDZ to alter 
inaccurate response rate, reflecting a progressive decline in this type of error with 
increasing dose. [IDZ:  F (3,45)=2.15, p=0.10].  There was a significant interaction of 
IDZ dose and cue duration [F (3,45)= 2.66, p=0.05], reflecting the fact that IDZ 
reduced inaccurate responses in the short [p=0.01] but not the long [p=0.51] cue 
condition (see figure 2.3). Moreover, the effect of IDZ under the short cue condition 
tended to be limited to those conditions where distractors were presented, [IDZ*cue 
duration*DISTRACT: F (6,332)=1.86, p=0.08], specifically the short cue “-1” 
distractor condition [p=0.001]; and the short cue “-2” distractor condition [p=0.04].  
There was no effect of IDZ on the short cue nondistraction trials [p=0.28]. 
 The timing of distractor presentation in relationship to trial onset (ie. the delay 
and distraction condition combination) also significantly affected the ability of IDZ to 
increase accuracy [IDZ*DELAY*DISTRACT: F (6, 332) =2.10, p=0.05]. Under 
conditions of distraction, IDZ’s enhancing effect was greatest when the distractors 
were presented one second after trial onset, specifically the 2 sec delay “-1” distractor 
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condition [p=0.01] and the 3 second delay “-2” second distractor condition [p= 0.02].  
There was a tendency for IDZ to also alter inaccurate responses in the 2 sec delay “-2” 
distractor condition [p=0.09] but not in the 3 sec delay “-1” distractor condition 
[p=0.74]. (See figure 2.4) IDZ did not significantly alter inaccurate responses on 
nondistraction trials in either of the two delay conditions, the 2 sec delay [p=0.78] or 
the 3 sec delay [p=0.66]. 
 Pb treatment did not alter inaccurate response rate [Pb: F (1,14)=0.47, p=0.50], 
nor was there a Pb treatment by IDZ dose interaction on this measure [Pb*IDZ: F (3, 
45)=0.62, p=0.60]. In no cases where the IDZ effects were significant did the effect 
differ between Pb and control groups [all p values > 0.5]. (See Figure 2.5) 
 
Figure 2.3.  IDZ significantly reduced percentage inaccurate responses only under the 
short cue condition (IDZ * cue duration, p = 0.05) (0.15 and 0.35 on this scale 
correspond to 2.2 and 11.8 % respectively.) 
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Figure 2.4.  IDZ significantly reduced inaccurate responses only under conditions of 
distraction and only when distractors were presented one sec. after trial onset, the 2 
sec. delay “-1” sec. distractor (p=0.01) and 3 sec. delay “-2” sec. distractor (p= 0.02) 
conditions. (0.18 and 0.32 on this scale correspond to 3.2 and 9.8 % respectively.)  
Figure 2.5.  The effect of IDZ on percentage inaccurate responses did not differ 
between Pb and control subjects.  Pictured here are the effects of IDZ on Pb and 
Control groups under the three conditions for which an overall IDZ effect was 
observed: the 2 second delay, -1 distractor condition (averaged across cue durations); 
the 3 second delay, -2 distractor condition (averaged across cue durations); and the 0.5 
second cue duration condition (averaged across delay and distraction conditions).  
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Premature Responses 
Premature responses were calculated as the percentage of trials in the session 
on which the subject made a response prior to light cue presentation.  Such a response 
terminated the trial and was considered an index of impulsivity and/or response 
inhibition. In order to reduce the proportion of zeros on this measure in the dataset, it 
was necessary to average data across delay and timing of distractor. There was no 
effect of Pb treatment on premature responses [Pb: F (1, 16)= 0.06 p=0.81], nor was 
there a Pb by IDZ interaction on this measure [Pb*IDZ: F (3, 48)= 0.55 p=0.64].  IDZ 
overall did not alter premature responses [IDZ: F (3, 48)= 0.83 p=0.48]. Mean percent 
premature responses were 4.03+5.40 and 3.84+5.36 for the control and Pb-exposed 
groups respectively. 
 
Omission errors 
Errors of omission were calculated as the percentage of trials in the session on 
which the subject entered the testing alcove, but failed to respond within 10 seconds of 
trial onset.  These errors were considered indicative of lapses of attention. There was 
no effect of Pb treatment on omission errors [Pb: F (1, 14)= 2.87, p=0.11], nor was 
there a Pb by IDZ interaction on this measure [Pb*IDZ: F (3, 42)= 1.34, p=0.27].  IDZ 
overall did not alter omission errors [IDZ: F (3, 42)= 0.54, p= 0.65].  Mean percent 
omission errors were 3.71+4.04 and 6.88+6.48 for the control and Pb-exposed groups 
respectively. 
 
Nontrials 
Pb treatment did not alter nontrials [Pb: F (1, 16)=1.41, p=0.25].  IDZ tended 
to decrease nontrials [IDZ: F (3, 190)=2.26, p=0.08] overall.  The effect of IDZ on 
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nontrials did not differ statistically as a function of Pb treatment [Pb*IDZ: F (3, 
190)=1.91, p=0.12]. 
 
DISCUSSION 
 
The results reported here have implications for both the nature and the 
neurochemical basis of lead-induced attentional deficits.  In addition, these results 
have implications for the role of NE in the modulation of normal attentional function.  
All three issues will be discussed below. 
 
Clarifying the nature of lead-induced dysfunction  
In study 1, both Pb treatment groups demonstrated a decrease in overall 
percentage correct on the distraction task. There was no effect of Pb treatment on 
premature responses, ruling out differences in inhibitory control as the basis of the Pb 
effect and indicating that this overall difference in percent correct was due to a Pb-
induced decrease in accuracy on the task. Pb treatment also did not significantly alter 
nontrial rate, ruling out differences in nonspecific performance factors such as 
motivation as the basis of the Pb effect and suggesting that both levels of Pb-exposure 
produced attentional deficits. The observation that these deficits were not limited to 
the trials on which distractors were presented suggests that these impairments were not 
related to Pb-induced increases in distractibility.   Rather, the increased error rate 
demonstrated by Pb-exposed subjects on both distraction and nondistraction trials was 
likely related to impairments of sustained or focused attention.  This interpretation is 
consistent with prior findings from this same cohort of animals when tested on visual 
discrimination and vigilance tasks (Strupp, et al, 1993).  Specifically, preliminary 
analyses suggested that Pb-exposure did not alter performance on a 3-choice visual 
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discrimination task in which the light cue was presented immediately at trial onset and 
remained illuminated until the rat responded.  However, both levels of Pb-exposure 
caused a decrease in overall performance on a vigilance task with a variable delay 
preceding presentation of a brief light cue.  This deficit appeared to be greater during 
conditions where delays preceded the cue relative to conditions when the cue was 
presented immediately at trial onset (Strupp, et al, 1993). The suggestion that Pb-
exposure impairs focused attention is also consistent with the lasting vigilance deficits 
demonstrated in studies of early postnatal Pb-exposure from this laboratory (Morgan, 
et al, 2001, Stangle, et al, 2007). In addition, the Pb-induced attentional dysfunctions 
observed in the current study are also consistent with impairments reported on the 
CPT by some groups (Bellinger, et al, 1994; Harvey, et al, 1988; Walkowiak, et al, 
1998) and with impairments on reaction time tasks that place increased demands on 
sustained attention in human children (Harvey, et al, 1988; Hunter, et al, 1985; 
Minder, et al, 1994; Needleman, et al, 1979; 1990; Raab, et al, 1990). Moreover, 
because the present study tested subjects in adulthood and the exposure regimen 
included a concurrent as well as an early (post-weaning) component, the observation 
that accuracy was impaired in Pb-exposed subjects on this attention task may also 
provide support for previous findings that link adult occupational Pb-exposure to 
deficits in attention (Pfister, et al, 1999; Stewart, et al, 1999; Tang, et al, 1995; 
Hogstedt, et al, 1983). 
It is also possible that the reductions in accuracy demonstrated by the Pb-
exposed subjects in the current study are related to alterations in the regulation of 
negative emotion or arousal.  This interpretation is consistent with the finding that the 
Pb-induced deficits in sustained attention reported by Morgan, et al (2001) and Stangle 
et al (2007) were most pronounced on trials following an error. In these studies, 
performance for all animals was disrupted on trials immediately following an error 
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(relative to trials following a correct response).  However, the performance- disrupting 
effects of prior errors were greater in Pb-exposed rats relative to controls. Although 
data on the effects of an error on prior trials were not collected in this study, it is 
possible that the impaired attention observed in the lead exposed rats in the present 
study were due, at least in part, to altered arousal and/or emotion.  
One additional possibility is that Pb-exposure increased sensitivity to the 
performance-disrupting effects of the distractors on this task.  The unpredictable 
presentation of potent distractors, such as those utilized in the present study, can result 
in a generalized disruption of performance, such that performance is disrupted on trials 
without distractors, as well as on trials with distractors (Arnsten and Contant, 1992). 
Thus, the observation in the current study that chronic post-weaning Pb-exposure 
decreased accuracy on both distraction and nondistraction trials may be due to a Pb-
induced increase in sensitivity to the performance disrupting effects of the distractors, 
again suggesting impaired arousal regulation or emotional reactivity in the Pb-exposed 
subjects. One or both of these types of impaired emotional regulation may have 
contributed to the attentional impairments in the current study.  Such increases in 
emotional regulation may be a contributing factor in the disruptive classroom behavior 
and increased delinquency rates associated with childhood Pb-exposure (Bellinger, et 
al, 1994; Davidson, et al, 2000; Dietrich, et al, 2001; Needleman, et al, 1996). 
It is notable that premature response rate did not differ among Pb treatment 
groups in the present study, suggesting that Pb-exposure did not alter inhibitory 
control, at least within the context of this distraction task.  This finding is consistent 
with other animal model studies of both early (Hastings, et al, 1979; Dietz, et al, 1978; 
Hopper, et al, 1986; Garavan, et al, 2000; Zenick, et al, 1979; Morgan, et al, 2001) and 
concurrent (Hilson & Strupp, 1997; Rice, 1988) Pb-exposure in which no effects on 
inhibitory control were demonstrated, and with some studies of the effects of human 
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childhood Pb-exposure on indices of inhibitory control (Baloh, et al, 1975; Bellinger, 
et al, 1994; Hansen, et al, 1989; Harvey, et al, 1988). 
 
NE involvement in Pb-induced attentional dysfunction 
A comparison of the effects of IDZ in the Pb and control animals sheds light 
on the hypothesis that NE alterations contribute to alterations in attention produced by 
Pb-exposure.  IDZ decreased inaccurate responses, specifically in response to 
distractors, a pattern that is likely to reflect IDZ’s effect on the coeruleocortical 
noradrenergic system that modulates selective attention and distractibility (Arnsten, et 
al, 1992; 1996; 1997; 2005; Aston-Jones, 1988; 1997; Bunsey and Strupp, 1995; 
Ramos and Arnsten, 2007; Robbins, et al, 1985; 1997; Sara, 1985; Sara, et al, 1988; 
discussed below). However, the two treatment groups did not differ in their response 
to IDZ on this measure, suggesting that alterations in the noradrenergic attentional 
system do not mediate the attentional dysfunction produced by Pb exposure.  
As noted in the Introduction, the available literature concerning the effects of 
Pb-exposure on NE function does not present a clear picture, very likely due to the 
numerous differences in the developmental timing, duration and intensity of lead-
exposure, as well as differences in the specific measure of NE function assessed. 
Consistent with our lack of differential drug effect in the Pb-exposed subjects, several 
groups have reported no effect of Pb-exposure on NE measures in brain regions 
relevant to attention:  telencephalon (McIntosh, et al, 1989), midbrain (McIntosh, et al, 
1989), forebrain (Grant, et al, 1976; Rossouw, et al, 1987; Silbergeld and Goldberg, 
1975), cortex (Grant, et al, 1976; Meredith, et al, 1988; Rossouw, et al, 1987; Sobotka 
and Cook, 1974; Sobotka, et al, 1975; reviewed in Moore, et al, 1986),  frontal cortex 
(Agrawal, et al, 1986),  hippocampus (Collins, et al, 1984; Meredith, et al, 1988; 
reviewed in Moore, et al, 1986), and striatum (Agrawal, et al, 1986; Bailey and 
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Kitchen, 1986; Baksi and Hughes, 1982; Grant, et al, 1976; McIntosh, et al, 1988; 
Sobotka and Cook, 1974; Sobotka, et al, 1975).  However, other groups have reported 
lead-induced increases in measures of NE in forebrain (Rossouw, et al, 1987; 
Silbergeld and Goldberg, 1975) and frontal, parietal, and occipital cortex (Freedman, 
et al, 1990); and both increases (Devi, et al, 2005; Dubas, et al, 1978; McIntosh, et al, 
1989; Kumar and Desiraju, 1990; Prasanthi, et al, 2005; Rossouw, et al, 1987) and 
decreases (Collins, et al, 1984; Devi, et al, 2005; Dubas, et al, 1978; Jason and 
Kellogg, 1981; McIntosh, et al, 1989; Prasanthi, et al, 2005; Rajanna, et al, 1997; 
Rossouw, et al, 1987) in midbrain (Dubas, et al, 1978; McIntosh, et al, 1989), 
hippocampus ( Devi, et al, 2005; Collins, et al, 1984; Kumar and Desiraju, 1990; 
Prasanthi, et al, 2005), cortex (Devi, et al, 2005; Prasanthi, et al, 2005; Rajanna, et al, 
1997; Rossouw, et al, 1987), and striatum (Dubas, et al, 1978; Jason and Kellogg, 
1981; Kumar and Desiraju, 1990). In addition, in contrast to the lack of Pb-induced 
differences in IDZ sensitivity reported here, both increased (Carter and Leander, 1980; 
Rafales, et al, 1981) and decreased (Carter and Leander, 1980; Grover, et al, 1993; 
Rafales, et al, 1981; Reiter, et al, 1975) sensitivity to NE drugs has been reported.  
Differences in level, timing, and duration of lead-exposure likely account for these 
widely discrepant results; utilization of several different exposure regimens within a 
study have been reported to produce different effects on the same NE parameters. 
(Collins, et al, 1984; Devi, et al, 2005; McIntosh, et al, 1988; 1989; Meredith, et al, 
1988; Prasanthi, et al, 2005; Rossouw, et al, 1987; reviewed in Moore, et al, 1986).  
It may be noted that, although Pb-exposure resulted in decreased accuracy on 
the distraction task in study 1, no attentional effects of Pb alone were seen in the 
similarly exposed Pb group in study 2 despite testing on a distraction task that was 
almost identical to that used in the first study.  The results of a subsequent study from 
this lab may shed light on why Pb-induced attentional impairments were not seen in 
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study 2.  Specifically, the toxin-induced impairment revealed by these tasks waned 
over time, suggesting that exposed animals, despite their attentional impairment, were 
eventually able to achieve “normal” levels of performance after extensive training on 
the task (Morgan, et al, 1997). Although data on performance during initial training on 
the distraction task is unavailable for the cohort of animals used in study 2, it is likely 
that these animals exhibited the same Pb-induced deficits exhibited by the similarly 
exposed subjects in study 1, but that this impairment decreased with their increasing 
experience on the task. It is therefore not surprising that the Pb and control animals did 
not differ in performance in study 2, after weeks of extensive training on the 
distraction task. However, the toxin-induced deficits revealed in the Morgan, et al 
(1997) study were found to re-emerge in the exposed subjects when challenged with 
IDZ or the selective D1 dopamine agonist SKF81297, drugs specific to neurochemical 
systems altered by the exposure (Bayer, et al, 2000; 2002). Thus, if NE alterations 
caused the attentional impairments demonstrated by Pb-exposed subjects in study 1, 
these differences should have re-emerged in response to the IDZ challenge in study 2. 
Therefore, the lack of a differential effect of IDZ on accuracy in the Pb-exposed 
subjects in study 2 suggests that the basis for the accuracy impairments identified in 
study 1 is not likely to be a Pb-induced alteration in noradrenergic activity.   It is 
particularly important to note that IDZ specifically altered accuracy in study two, the 
same measure on which Pb-induced deficits were revealed in study 1. Thus, the two 
studies used the same Pb-exposure regimen and the same outcome measure to both 
identify the Pb-induced cognitive impairments and to examine the role of NE in these 
impairments.  This convergence allows inferences to be drawn about the 
neurochemical basis for these Pb-induced attentional deficits, without the problems 
associated with methodological differences discussed above (eg. differences in timing, 
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level, and duration of Pb exposure or differences in outcome measures between 
studies). 
 
NE modulation of normal attentional function 
The observed pattern of IDZ effects in study 2 is consistent with the posited 
role of NE activity in normal attentional function.  Improved performance was seen 
only for a specific response type (accuracy) and only under the most attentionally 
demanding conditions (shorter cue duration, presentation of distractors). This pattern 
of effects rules out changes in nonspecific performance factors such as motivation or 
motor behavior as the basis of the drug effect.  In this study, IDZ appeared both to 
enhance attentiveness to target stimuli by increasing accuracy under the short cue 
condition and to inhibit attention to distractors by enhancing performance under 
conditions of distraction.  Because IDZ increases firing of the LC through its actions at 
presynaptic alpha-2 receptors, and thus increases coeruleocortical NE activity 
(Aghajanian, et al, 1977; Dennis, et al, 1987), this pattern of results provides support 
for the theory that LC activity and cortical NE release modulate selective attention 
(reviewed in Aston-Jones, 1988; 1997; Foote, et al, 1983; Sara, et al, 1988). 
 It is notable that IDZ’s performance enhancing effect was most prevalent under 
conditions where distractors were presented 1 second after trial onset.  Distractors 
administered at this time have proven to be most disruptive to rats in several studies in 
our laboratory (Gendle, et al, 2004). Electrophysiological data suggest a possible 
mechanism for this effect.  Recordings from delay active neurons in the principal 
sulcus of monkeys during working memory tasks reveal that 80% of these neurons 
exhibited peak activity in the first few seconds of the delay period (Goldman-Rakic, 
1987).  Presentation of distractors or electrical stimulation of this region are most 
disruptive to performance when they occur at this time, suggesting that these early 
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seconds are the most crucial for processing.  Although these data were recorded during 
performance of delayed response and delayed alternation tasks, there is evidence to 
suggest that this finding has implications for tasks of attention as well as working 
memory.  Specifically, the anatomical convergence of delay-locked 
electrophysiological activity in the sulcus principalis in primate studies of both 
working memory (see Goldman-Rakic, 1987; 1990 for review) and attention (Lecas, 
1995) suggests that these functions may be mediated by the same populations of 
neurons (Lecas, 1995).  Thus, the conditions in our study in which distractors were 
presented 1 second into the trial were most distracting because these conditions 
occurred during the most physiologically crucial processing period.  It is also relevant 
that the drug showed a tendency to enhance performance when the distractor was 
presented immediately at trial onset (the 2 second delay, -2 distractor condition), but 
had no effect on performance during either the nondistraction trials or the condition 
when the distractor was presented 2 seconds into the trial (the 3 second delay, -1 
distractor condition).  During this condition, the distractors were presented after the 
posited most physiologically crucial processing period, and were therefore presumably 
less distracting.  The finding that the beneficial effect of IDZ was limited to the most 
distracting conditions is consistent with the hypothesized role of the coeruleocortical 
NE pathway in selective attention and distractibility (Arnsten, et al, 1992; 1996; 1997; 
Aston-Jones, 1988; 1997; Bunsey and Strupp, 1995; Ramos and Arnsten, 2007; 
Robbins, et al, 1985; 1997; Sara, 1985; Sara, et al, 1988), suggesting that the IDZ-
induced decrease in inaccurate response rate is likely related to the drug- induced 
increase in LC activity. 
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Summary  
 In the present series of studies, Pb-exposed subjects demonstrated significant 
impairments in accuracy relative to controls on a distraction task.  IDZ selectively 
increased accuracy in this task, consistent with the role of coeruleocortical NE in 
modulating selective attention and distractibility.  However, the effect of IDZ on 
attention on this task did not differ between lead treatment groups.  Taken together, 
these findings suggest that Pb-exposure causes specific deficits in attention and/or 
arousal regulation, but that Pb-induced alterations in alpha-2 mediated NE activity do 
not underlie this dysfunction. 
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CHAPTER 3 
 
PRENATAL COCAINE EXPOSURE ALTERS SENSITIVITY TO THE 
EFFECTS OF IDAZOXAN IN A DISTRACTION TASK∗ 
 
ABSTRACT 
 
The present study was designed to test whether prenatal cocaine (COC) 
exposure alters sensitivity to the attentional effects of idazoxan (IDZ), an alpha-2 
adrenergic antagonist that increases coeruleocortical NE activity (Aghajanian, et al, 
1977; Dennis, et al, 1987).  The task assessed subjects' ability to selectively attend to 
an unpredictable light cue and disregard olfactory distractors.  IDZ increased 
commission errors specifically under conditions of distraction, an effect that was 
similar in the COC and control groups.   In contrast, COC animals were significantly 
more sensitive than controls to the effects of IDZ on omission errors and nontrials. 
The pattern of effects suggests that the differential treatment response to IDZ on these 
latter measures resulted from an alteration in norepinephrine (NE)-modulated 
dopamine release in the COC animals, reflecting lasting changes in dopaminergic 
and/or noradrenergic systems as a result of the early cocaine exposure. Based on the 
behavioral measures that showed a differential response to IDZ in the COC animals, it 
seems likely that these changes may contribute to the alterations in sustained attention 
and arousal regulation that have been reported in both animals and humans exposed to 
cocaine in utero.   
                                                
∗ Bayer LE, Kakumanu S, Mactutus CF, Booze RM, Strupp BJ (2002) Prenatal 
cocaine exposure alters sensitivity to the effects of idazoxan in a distraction task. 
Behavioral Brain Research 133: 185-196. 
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INTRODUCTION 
             
Each year, thousands of infants are exposed to cocaine in utero.   Although 
initial reports of devastating neurobehavioral consequences of prenatal cocaine 
exposure were not substantiated, more recent controlled studies provide evidence for 
subtle, but functionally significant, alterations in cognition and neurochemistry.  
Several studies suggest that prenatal cocaine exposure causes attentional impairments 
in children (Azuma and Chasnoff, 1993; Beckwith, et al, 1995; Karmel and Gardner, 
1996; Leech, et al, 1999; Mayes, et al, 1998; Richardson, et al, 1996).  Although many 
of these studies are difficult to interpret due to confounding factors such as polydrug 
abuse and poor postnatal care, a recent study has identified attentional impairments in 
cocaine-exposed children in a population where such confounding was reduced 
(Richardson, et al, 1996).  In this study, prenatal cocaine exposure caused an increase 
in omission errors on the Continuous Performance Test (CPT), indicative of 
impairment in sustained or focused attention.  Similarly, studies using a rat model of 
intravenous (IV) prenatal cocaine exposure revealed deficits in both focused and 
selective attention in adult animals, long after the period of exposure (Bushnell, et al, 
2000; Garavan, et al, 2000; Morgan, et al, 1997; Strupp, et al, 1998).  Similarly, 
behavioral changes indicative of altered selective attention have also been reported in 
studies using both rabbit (Romano and Harvey, 1996) and mouse (Gabriel and Taylor, 
1998) models of prenatal cocaine exposure.  Identification of the specific neural 
changes that underlie these attentional deficits is needed to develop drug therapies that 
may ameliorate the dysfunction.   This goal motivated the present study.  
Damage to the coeruleocortical noradrenergic system is a plausible cause of 
the attentional dysfunction produced by prenatal cocaine exposure.  Considerable 
evidence implicates the coeruleocortical NE system in various aspects of normal 
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attentional processing, including selective and focused attention (see Arnsten, et al, 
1996; Aston-Jones, et al, 1999; Aston-Jones, 1988; Bunsey and Strupp, 1995; 
Bushnell, 1998; Clark, et al, 1987a; Clark, et al, 1987b; Robbins, 1997; Sara, 1985; 
Sara, et al, 1988 for review), scanning attentiveness (Aston-Jones, et al, 1999) and 
alerting (Marrocco and Davidson, 1998).  Moreover, previous work in our lab suggests 
that idazoxan, a drug that increases NE release from the LC (Aghajanian, et al, 1977; 
Dennis, et al, 1987), specifically alters selective attention (Bayer and Strupp, 1995; 
Bunsey and Strupp, 1995) in the same distraction task that revealed altered selective 
attention in rats exposed to cocaine prenatally.  In addition, reduced tyrosine 
hydroxylase immunostaining in the LC (Booze, 2000, personal communication) has 
recently been reported for the same IV rat cocaine model that was used in the studies 
demonstrating lasting attentional changes as a result of prenatal cocaine exposure.  
These findings, taken together, suggest that the lasting attentional changes produced 
by prenatal cocaine exposure may be due to underlying changes in the coeruleocortical 
NE system.  
Unfortunately, the literature concerning the effects of prenatal cocaine 
exposure on central noradrenergic function does not present a clear picture, for several 
reasons.   First, previous studies of the effects of prenatal cocaine exposure on various 
functional measures of central NE activity have yielded results that are inconsistent 
with regard to both the presence and direction of prenatal cocaine’s effects.  Such 
findings have been reported for NE concentration (Vathy, et al, 1993), turnover 
(Seidler and Slotkin, 1992), receptor number (Booze, et al, 1994; Henderson, et al, 
1991; Seidler and Slotkin, 1992; Wallace, et al, 1996), sensitivity to adrenergic drugs 
(Byrnes, et al, 1993; Cutler, et al, 1996; Kunko, et al, 1996; Meyer, et al, 1992; Peris, 
et al, 1992; Simansky and Kachelries, 1996), and tyrosine hydroxylase activity 
(Akbari, et al, 1992; Booze, et al, 1994; Meyer and Dupont, 1993).  The lack of 
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consistency in results may reflect, at least in part, the fact that different routes of 
administration (intragastric (PO), subcutaneous (SC), or intravenous (IV)) and widely 
varying cocaine doses were used in these studies.  An additional limitation of the 
existing work is that the significance of the reported neural changes for behavior or 
cognition has not been assessed in most studies.   In summary, the available data on 
CNS noradrenergic changes in animal models of prenatal cocaine exposure do not 
provide conclusive evidence for or against the hypothesis that changes in this system 
underlie the reported attentional dysfunction.  
The present study used a drug challenge design to test this hypothesis.  
Cocaine was administered intravenously (IV), the route that most closely mimics the 
rapidly peaking pharmacokinetic profile and peak arterial plasma levels that are seen 
following recreational cocaine inhalation or IV injection in humans (Booze, et al, 
1997; Evans, et al, 1996).  Adult offspring were administered a range of doses of 
idazoxan (IDZ), an alpha-2 adrenergic antagonist that increases firing of the LC 
(Aghajanian, et al, 1977; Dennis, et al, 1987), prior to testing on an attentional task.  
IDZ dose-effect curves for cocaine-exposed and control subjects were compared.  
This study was designed to provide information on the lasting effects of prenatal 
cocaine exposure on the noradrenergic system, as well as information about the 
functional consequences of these putative changes.  
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MATERIALS AND METHODS 
 
Subjects 
Nulliparous Long Evans rats (Harlan Sprague Dawley, Indianapolis, IN), 
approximately 11 weeks old, were housed in AAALAC-accredited animal facilities 
maintained at 21 ± 2°C, 50% ± 10% relative humidity with a 12 hour light: 12 hour 
dark cycle. Food (Pro-Lab Rat, Mouse, Hamster Chow No. 3000) and water were 
available ad libitum.  Subjects were randomly assigned to either receive a surgical 
catheterization procedure (described below) or to serve as unoperated surrogate 
controls.  Following surgery, subjects in the catheterization group were randomly 
assigned to receive either cocaine (COC) or saline (SAL; vehicle control). This 
research protocol was approved by the animal care review boards of the University of 
Kentucky and Cornell University. 
 
Catheterization 
Subjects in the catheterization group were surgically implanted with a sterile 
IV catheter (described in detail in Mactutus, et al, 1994).  The distal end of the 
catheter was inserted into the jugular vein and threaded centrally.  The proximal end 
of the catheter, including the injection cap, was left as a small SC pouch on the dorsal 
surface of the animal through which chronic IV injections were made.  Catheter 
patency was maintained by daily flushing with 0.2 ml of heparinized saline (2.5%). 
 
Mating 
After recovery from surgery (4-8 days) the females were group-housed (n=3) 
with a male rat.  Daily vaginal lavage of each female was performed to keep track of 
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estrus cycles and to assist in defining conception.  Conception (gestational day 0, or 
GD0) was confirmed by a sperm-positive lavage. 
 
IV Drug Injection 
 IV drug administration procedures were conducted as described in Mactutus, et 
al. (Mactutus, et al, 1994).  Briefly, all dams received daily IV saline injections 
(1ml/kg) from conception until gestational day (GD) 7.  Dams in the saline subgroup 
(n=8) continued to receive IV saline injections once per day from GD8-14 and twice 
daily from GD15-21.  Dams in the cocaine subgroup (n=8) received cocaine 
hydrochloride (3.0mg/ 1ml /kg, IV; Research Triangle Institute, NC) once per day 
from GD8-14 and twice daily from GD15-21.  The drug was dissolved immediately 
prior to injection.   
This regimen (route, dose, and rate) produces no evidence of overt maternal or 
fetal toxicity, no maternal seizure activity, no effect on maternal weight, and no effect 
on offspring growth or mortality (e.g., Mactutus, 1999; Mactutus, et al, 1994). 
Furthermore, an IV injection procedure model by Robinson, et al demonstrated that 
IV administration of cocaine does not reduce food intake of dams even when utilizing 
a cocaine dose as high as 6 mg/kg (Robinson, et al, 1994). 
  
Offspring treatment 
Within 24 hours of birth, pups were weighed, culled to 4 males and 4 females 
per litter (when possible), and fostered to a surrogate dam that had given birth within 
the preceding 24 hours.  Fostering was conducted for both cocaine (COC) and saline-
exposed (SAL) offspring in order to remove potential effects of gestational cocaine 
treatment on maternal behavior as a source of offspring differences.  On postnatal day 
21 (PND21), pups were weaned and earpunched for identification.  Within 10 days of 
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weaning, one male and one female offspring from each litter were transported under 
environmentally-controlled conditions from Lexington, KY to Ithaca, NY (Cornell 
University).  Upon arrival, subjects were housed in same sex pairs on a reversed 
dark/light cycle and allowed to acclimate to the new environment for 2-3 weeks.  
Training/ behavioral testing began for all animals on PND48.   The animals were 
approximately 160 days of age at the beginning of the present study.    The subjects 
tested in the current study consisted of 14 cocaine-exposed (7 male, 7 female) and 15 
saline-exposed (7 male, 8 female) offspring.  
 
Behavioral testing 
Apparatus 
Testing was conducted in 12 automated Plexiglas chambers enclosed in 
sound-attenuating wooden boxes, each operated by an IBM PC XT computer with an 
8088 processor.  Each chamber consisted of a square waiting area (26.5 cm by 25 cm 
by 30 cm), adjacent to a testing alcove containing three funnel-shaped ports.  An 
LED was mounted above each port.  A thin metal door, raised at the initiation of each 
trial, separated these two compartments. The left and right ports were at an 
approximate 45° angle relative to the center port and the distance between the left and 
right ports was 8 cm.  Each port was connected by tubing to three bottles containing 
liquid odorants, attached to a board placed outside of the box.   Solenoid valves 
controlled the presentation of compressed air, pumped through a specific odorant and 
through a specific port.   The airflow rate was 1.0 L/min and the air in the chamber 
was cleared via small centrifugal fans mounted on the outside of the chambers, at a 
rate of four complete exchanges per minute.  A set of infrared phototransistors and a 
light source monitored the entrance to the alcove and each port.  A nose-poke of ≥ 1 
sec into one of the three ports constituted a response.  Correct responses were 
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reinforced with a 45 mg food pellet (Noyes, Lancaster, NH) delivered into the alcove 
from a pellet dispenser (Lafayette Instrument Co., Lafayette, IN). 
 
Prior behavioral testing 
Subjects had been trained on several attentional tasks as part of a previous 
experiment (see Morgan, et al, 1997; 2002): 1) a three-choice brightness 
discrimination task in which the correct port was designated by the illumination of an 
LED mounted over that port; 2) a series of vigilance tasks in which the interval 
between trial onset and cue illumination varied, as did the duration of the light cue; 
and 3) a variant of the distraction task described below.     
 
Distraction Task 
Prior to initiation of the present IDZ challenge study, subjects received 12 
days of testing on the distraction task to achieve a stable baseline performance level 
for each rat. Testing was conducted by personnel who were blind to prenatal 
treatment condition. The opening of the alcove door signaled the onset of each trial.  
After the subject entered the testing alcove, one of the three LEDs was illuminated.  
Several parameters were randomly varied across the trials in the session:  1) pre-
stimulus delay (2 or 3 seconds after alcove entry); 2) stimulus duration (300 or 700 
msec); and 3) presentation and timing of distractors:  On 1/3 of the trials in each 
session, one of nine different odors was delivered through one of the three ports, 
either one second (“-1 distractor condition”) or two seconds (“-2 distractor 
condition”) prior to visual cue onset.  No odors were presented on the remaining two 
thirds of the daily trials (nondistraction trials).  The delay, duration, cue location, and 
distraction condition for each trial were selected pseudorandomly, balanced for each 
session. A 1-sec nose-poke into the port under the illuminated light resulted in 
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delivery of a 45 mg pellet (Noyes, Lancaster, NH) and ended the trial, signaled by the 
closing of the alcove door.  A nose-poke of ≥ 1 second into any port prior to the light 
cue onset, into an incorrect port following the cue, or a failure to respond within 15 
seconds of light cue offset ended the trial with no reinforcement.  If the animal failed 
to enter the alcove within 30 seconds, the alcove door closed and a nontrial was 
recorded.  An intertrial interval of 5 seconds was imposed between successive trials. 
A variant of this task had previously revealed enduring effects of prenatal cocaine 
exposure in this cohort of animals (see Morgan, et al, 1997; 2002). 
 
Idazoxan challenge study 
IDZ (0.0, 0.5, 1.0, 1.5 mg/ml/kg; Research Biochemicals, Inc, Natick MA) 
was dissolved in sterile MilliQ water (Millipore, Bedford, MA) immediately prior to 
each daily session and was administered subcutaneously 15 minutes prior to testing.  
Each subject received each of the 4 doses 5 times, with dose order determined by a 
Latin Square design.  48 hrs were imposed between successive injection days to allow 
clearance.  Daily sessions consisted of 100 trials or 60 minutes, whichever came first. 
Subjects were maintained on a restricted feeding schedule to maintain 
adequate motivation.  The daily food ration for each rat had been determined in a 
previous study (Garavan, et al, 2000).  Our goal had been to identify the minimal 
food restriction that would produce a low number of non-trials and a high rate of 
response trials. Subjects were weighed daily to ensure that body weight was stable or 
slowly increasing.  The COC and control groups did not differ in the daily food 
allotment (Garavan, et al, 2000). 
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Response types   
Percentage correct and nontrials were calculated for each session.  In addition, 
the following error types were calculated (defined in results section): Premature 
responses, inhibition errors (premature responses specifically to the odor distractor), 
inaccurate responses, and omission errors. 
 
Statistical Analysis 
Data were analyzed using the SAS PROC MIXED mixed models procedure 
for analyzing linear models that contain both fixed and random factors. The MIXED 
procedure uses maximum likelihood estimation to account appropriately for the 
correlated structure within repeated measures designs. The factors litter (within 
treatment) and sex (within litter and treatment) were used to create three levels of 
variability for this multi-tiered model (within-litter, within-animal, and residual).  
However, in some cases, either the within-litter or the within-animal variance 
component was estimated to be zero, indicating that after adjusting for the systematic 
differences of the fixed effects, there was a redundancy in the sources of variation.  In 
those cases, the within-animal term was included as the sole variance component. 
The Satterthwaite correction was used in all cases to determine the correct 
denominator degrees of freedom.  
To achieve a more normal distribution, percentage correct and percentage 
error-type data were calculated across all five sessions of a given dose for each rat 
and then transformed using an arcsin square-root transformation prior to analysis. 
Percentage correct was analyzed as a function of prenatal treatment (termed COC), 
sex, IDZ dose (termed IDZ), pre-stimulus delay, light cue duration, distraction 
condition, and the relevant interactions of these variables.  Similar analyses were 
conducted on the various types of errors: percentage accuracy errors, percentage 
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premature responses, percentage inhibition errors, and percentage omission errors.  
For the analysis of omission error rate, the outcome of the previous trial (correct or 
incorrect; a variable referred to as “PREV”) was also included in the model because 
previous data suggested that omissions errors most often occur on trials following 
errors. In addition, nontrials were analyzed as a function of prenatal cocaine 
treatment, sex, IDZ dose, and the relevant interactions of these variables. In all of 
these analyses, the critical test of differential sensitivity of the treatment groups to 
IDZ was an interaction of prenatal treatment and IDZ. 
 
RESULTS 
 
Dam and Pup Data 
Prenatal cocaine treatment did not alter maternal weight gain during gestation 
(measured on GD 0, 8, 15, and 21), as evidenced by the absence of a main effect for 
prenatal treatment [(F(1,18) = 1.01, p < 0.33], and the absence of an interaction of 
day and COC [F(2,36) <1].   Similarly, there was no effect of cocaine treatment on 
average maternal gestation weight gain (F(1,18) = 1.15, p < 0.30), gestation length 
(F(1,18) = 1.00, p < 0.33), litter sex ratio (F(1,18) <1), pup birthweight on PND1 
[(F(1,18)<1], or litter size [F(1,18) <1]. Finally, there was no effect of cocaine 
treatment on offspring growth (body weight) or survival [all F’s < 1]. 
 
Percentage Correct 
Percentage correct was calculated as the percentage of response trials in the 
session in which a correct response was made.  Response trials were defined as trials 
on which the animal entered the testing alcove.  Percentage correct was lowest under 
conditions of greatest attentional demand:  trials with the shorter cue length (300 ms) 
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[Duration: F(1, 1329)=250.37, p≤ 0.0001], trials on which a distractor was presented 
[Distraction condition: F(2, 1329)=13.78, p≤ 0.0001], and trials with a longer pre-
stimulus delay [Delay:  F(1, 1329)=39.14, p≤ 0.0001].  Prenatal treatment (COC) did 
not significantly alter percentage correct [F(1,13)<1], nor was there a COC by IDZ 
interaction for this measure [F(3,1329)<1]. There was a significant main effect of IDZ 
[F (3, 1329)=5.46, p≤0.001], as well as an interaction of IDZ and Distraction condition 
[F(6, 1329)=2.84 p≤0.01].  As seen in figure 3.1, this interaction reflected the fact that 
the impairing effect of the drug was limited to the –2 distractor condition, which refers 
to trials in which the distractor was presented 2 seconds prior to onset of the light cue 
[IDZ effect in the –2 distractor condition: F(3,1329)=7.69 p≤0.0001].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.   IDZ significantly decreased percent correct specifically when the 
distractor was presented 2 s before cue onset (the “-2” distractor condition) 
(p≤0.0001).  The drug did not affect performance on trials without distractors or when 
the distractor was presented 1 s before cue onset.  Points represent mean + SEM.  
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Inaccurate Responses (“timely” responses to the wrong response port) 
An inaccurate response was defined as a response made to an incorrect port 
after light cue presentation but within 10 seconds of trial onset.   For each condition, 
the percentage of inaccurate responses was calculated by dividing the number of 
inaccurate responses by the total number of response trials in that condition. The 
percentage inaccurate responses was highest under conditions of greatest attentional 
demand; i.e., trials on which the shorter cue was presented [DURATION:  F(1, 
1330)=64.43, p≤0.0001] and trials with distractors [Distraction condition: F(2, 
1330)=3.01, p≤0.05].  The percentage of inaccurate responses was not significantly 
affected by Prenatal Treatment [F(1,16) < 1]. There was neither a significant COC by 
IDZ interaction [F(1,1330)< 1], nor a significant COC by IDZ by DISTRACTION 
interaction [F(2,1330) < 1].  The main effect of IDZ was not significant [F(1, 1330) < 
1], but there was a significant interaction of IDZ and DISTRACTION 
[F(2,1330)=4.43, p≤0.01].  As may be seen in Fig. 3.2a, this interaction reflected the 
fact that IDZ only affected the rate of inaccurate responses in the –2 distractor 
condition [IDZ effect in the –2 distractor condition: p≤0.03]. A linearly increasing 
effect of IDZ dose was seen in this condition.  IDZ had no effect on inaccurate 
responses in either the nondistraction [IDZ effect in the nondistraction condition: p≤ 
0.62] or the –1 distractor  [IDZ effect in the –1 distractor condition: p≤0.15] 
conditions. The main effect of Sex was not significant [F(1,17) < 1], but the effect of 
IDZ differed significantly between the sexes [Sex*IDZ:  F(1,1330)=10.87, p≤0.001].  
As seen in Fig. 3.2b, males were significantly impaired by IDZ [F(1,638)=6.44, 
p≤0.01], whereas females were significantly improved by IDZ [F(1,685)=4.69, 
p≤0.03]  The interaction of Sex, IDZ dose, and distraction condition was not 
significant. 
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Figure 3.2.  Effect of IDZ on the percentage of total response trials in which an 
inaccurate response was made. Points represent mean + SEM. (0.29 and 0.35 on this 
scale correspond to 8.2 and 11.8 % respectively).  Left panel: IDZ significantly 
increased the percentage inaccurate responses specifically in the "-2" distractor 
condition (IDZ * distraction, p ≤ 0.01).  The drug did not affect the rate of inaccurate 
responses on trials without distractors or when the distractor was presented 1 s before 
cue onset. Right panel:  The effect of IDZ on percentage inaccurate responses differed 
between male and female rats (Sex * IDZ, p≤0.001); males were significantly 
impaired by IDZ [p≤0.01], whereas females were significantly improved by IDZ 
[p≤0.03]. See text for discussion 
 
Premature Responses 
Premature response rate was calculated as the percentage of trials in the 
session on which the subject made a response prior to light cue presentation.  This 
type of response terminated the trial and was considered an index of impulsivity 
and/or deficient response inhibition. In order to reduce the proportion of zeros in this 
measure in the dataset, it was necessary to average across Cue Duration, Pre-stimulus 
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Delay, and Distraction Condition.  The analyses revealed that premature response rate 
was not significantly altered by prenatal cocaine exposure [F(1,13) < 1].  IDZ also did 
not affect this measure [F(3,75)=1.11, p≤0.35], nor was there a COC by IDZ 
interaction [F(3,75)< 1]. 
 
Inhibition errors 
An inhibition error was defined as a premature response made in response to 
the olfactory distracter.  This measure was calculated as the total number of premature 
responses made to any port, prior to the presentation of the light cue but after the 
presentation of the olfactory distracter, divided by the total number of distraction trials 
in the session.  In order to reduce the proportion of zeros on this measure in the 
dataset, it was necessary to average data across Cue Duration, Pre-stimulus Delay, and 
timing of the distracter.  Prenatal cocaine treatment did not alter the percentage of 
inhibition errors [F(1,13) < 1], nor was there a COC by IDZ interaction  [IDZ:  F(3,75) 
< 1].  As depicted in Fig. 3.3, IDZ significantly altered the inhibition error rate overall 
(F(3,75)=2.90, p≤0.04), reflecting the fact that the lowest dose of IDZ increased this 
error type. (IDZ: vehicle vs low dose: F(1,75)=4.79, p≤0.03).  The effect of IDZ on 
inhibition errors tended to differ  between the two sexes [sex*IDZ:  F(3,75)=2.50, p ≤ 
0.07].  Although the two sexes did not differ at any dose, the peak of the inverted-U 
shaped IDZ dose-effect curve appeared shifted to the right in females relative to males 
(see Fig. 3.4), suggesting that the male rats were more sensitive to the drug effect on 
this measure than females.  This inference is based on the pattern of dose effects in 
each sex.  Specifically, within the males, the overall drug effect [F(3,75)=2.45, p ≤ 
0.07] reflected the significant increase in inhibition errors seen at the lowest dose 
relative to saline [p≤0.01].  In contrast, within the females, the drug also affected 
inhibition errors [F(3,75)=2.96, p≤0.04], but the only dose that tended to differ from 
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the vehicle condition was the medium dose [p≤0.06]; no effect was seen at the lower 
dose [p≤0.57], in contrast to the males.   The highest dose of IDZ did not increase 
inhibition error rate in either sex.   
 
Figure 3.3. The lowest dose of IDZ significantly increased inhibition error rate 
relative to the vehicle condition (p≤0.04).  Inhibition errors refer to premature 
responses made in response to the olfactory distractors. Bars represent mean + SEM.  
(0.13 and 0.19 on this scale correspond to 1.7 and 3.6 % respectively.)   The * denotes 
significantly different from the vehicle injection.  
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Figure 3.4. Male rats tended to be more sensitive than females to IDZ’s effect on 
inhibition errors (sex * IDZ, p≤0.07). The pattern of effects suggests that the peak in 
the dose-effect curve is shifted to the right in the males relative to the females.  Points 
represent mean + SEM. See text for discussion.  (0.13 and 0.19 on this scale 
correspond to 1.7 and 3.6 % respectively.) 
 
Omission errors 
Errors of omission were calculated as the percentage of trials in the session on 
which the subject entered the testing alcove but failed to respond within 10 seconds of 
trial onset.  In order to reduce the proportion of zeros in this measure in the dataset, it 
was necessary to average across the Delay and Distraction variables.  The analysis 
revealed that, overall, subjects made more omission errors when presented with the 
shorter light cue relative to the longer cue [F(1, 391)=8.62, p≤0.004]. There was a 
significant main effect of IDZ [F(3,391)=4.88, p≤0.002], reflecting the fact that each 
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of the three doses increased omission errors relative to the vehicle (p’s for the low, 
medium, and high doses were 0.0002, 0.04, and 0.02, respectively.) The effect of 
prenatal treatment was not significant [F(1,29)<1], but significant interactions were 
seen for the interaction of COC and IDZ [F(3, 391)=2.93, p≤0.03; see figure 3.5], and 
the four-way interaction of COC, IDZ, SEX, and outcome of the previous trial 
[F(3,391)=3.47, p≤0.02]. To further elucidate the basis of both interactions, 
subsequent contrasts were conducted.  These contrasts revealed that a significant 
interaction of COC by IDZ (the test of a treatment difference in IDZ sensitivity) was 
seen only in female subjects, on trials following errors [COC*IDZ in females after 
errors:  F(3, 90)= 7.27, p≤0.0002]. There was no COC by IDZ interaction for females 
on trials that followed a correct trial [F(3,91.1)<1] or in males after either correct [F(3, 
83.9)=1.36, p≤0.26] or incorrect trials [F(3, 84.8)<1].  As depicted in figure 3.6a, the 
significant treatment difference in IDZ response in the females, on trials that followed 
an error, reflects an apparent shift to the left of the inverted-U shaped IDZ dose-
response curve in the COC group relative to the SAL group.  For COC females, the 
overall effect of IDZ on trials following errors [p≤0.0004] reflected the significant 
increase in omission error rate produced by the lowest dose (relative to vehicle; 
p≤0.003].  For SAL females, IDZ also increased omission errors on trials following 
errors [p≤0.02], but this effect was limited to the highest dose of IDZ [high dose vs 
vehicle for SAL females after errors: p≤0.04]. 
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Figure 3.5.  COC rats were more sensitive than controls to IDZ’s effect on omission 
error rate (COC*IDZ, p≤0.05).  Points represent mean + SEM. (0.13 and 0.20 on this 
scale correspond to 1.7 and 3.9 % respectively) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. The increased sensitivity of COC rats to IDZ’s effect on omission errors 
was limited to the females, on trials that occurred after an error. Points represent mean 
+ SEM.  Left panel: On trials that followed an error, COC females were impaired by 
the lowest dose of IDZ (p≤0.002), whereas for SAL females, only the highest IDZ 
dose significantly increased omission errors relative to vehicle (p≤ 0.04). Right panel: 
There was no effect of IDZ in male rats of either treatment group. (0.13 and 0.35 on 
this scale correspond to 1.7 and 11.8% respectively.)  
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Nontrials 
Nontrial rate was significantly affected by prenatal cocaine treatment 
[F(1,25)=4.70, p≤0.04], and Sex [(F(1,25)=8.50, p≤0.007)], and a borderline overall 
effect was seen for IDZ [F(3,75)=2.44, p≤0.07].  In addition, the two prenatal 
treatment groups responded differently to IDZ, as demonstrated by a significant 
interaction of COC and IDZ [F(3,75)=2.95, p≤0.04].  As depicted in figure 3.7, this 
significant interaction reflected the fact that IDZ significantly increased nontrials in 
the COC subjects [p≤0.003], but not in the SAL subjects [p≤0.83].  A borderline three-
way interaction of COC, SEX, and IDZ [F(3,75)=2.30, p≤0.08] was also observed, 
suggesting that the two sexes might be differentially vulnerable to prenatal cocaine 
exposure’s effect on sensitivity to IDZ.   This suggestion prompted an assessment of 
the IDZ effect in each of the four subgroups defined by sex and prenatal treatment  
(COC female, COC male, SAL female, and SAL male), to avoid making erroneous 
conclusions about the generality of the effects across gender.  Because these four 
contrasts were performed despite the fact that the interaction term did not achieve 
classical levels of significance (p ≤ .05), an alpha of 0.0125 was used to correct for 
multiple testing.  As depicted in figure 3.8, the borderline three-way interaction of 
COC, SEX, and IDZ reflected the fact that IDZ increased nontrials only in the COC 
females [F(3,75)=7.53, p≤0.0002], an effect that was driven by the lowest dose. IDZ 
did not increase nontrials in the COC males [F(3,75)=1.27, p≤0.29], nor in the SAL 
animals of either gender [SAL females: [F(3,75) < 1; SAL males: F(3,75) < 1].  
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Figure 3.7. Cocaine exposure increased sensitivity to the effect of IDZ on nontrials 
(COC*IDZ, p≤0.04) IDZ significantly altered nontrials in the COC subjects 
[p≤0.003], but not the controls [p≤0.83]. Points represent mean + SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8.   The treatment group difference in sensitivity to the effect of IDZ on 
nontrials appeared to be driven by differences in the females.  IDZ increased nontrials 
only in the COC females  [p≤0.0002], not in the SAL females, or either group of male 
subjects. Points represent mean + SEM. 
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DISCUSSION 
 
A comparison of the effects of IDZ in the COC and control animals sheds light 
on the hypothesis that catecholaminergic alterations contribute to the lasting cognitive 
and affective alterations produced by prenatal cocaine exposure.  One effect of IDZ 
was to increase the rate of commission errors (inaccurate responses, inhibition errors) 
specifically in response to distractors, a pattern that likely reflects the drug’s effect on 
the coeruleocortical noradrenergic system (Arnsten, 1997; Arnsten and Contant, 1992; 
Arnsten, et al, 1996; Aston-Jones, et al, 1997; Aston-Jones, 1988; Bunsey and Strupp, 
1995; Robbins, 1997; Robbins, et al, 1985; Sara, 1985; Sara, et al, 1988; discussed 
below).  Whereas the effects of IDZ on commission errors were similar in the COC 
and SAL animals, the analyses of two other measures (omission errors and nontrials) 
revealed a significant interaction of IDZ and Prenatal Treatment, the critical finding 
considered indicative of an enduring neurochemical effect of prenatal cocaine 
exposure.  Specifically, as discussed below, the pattern of IDZ effects seen for these 
latter two variables suggests that the COC animals may be more sensitive than 
controls to the drug effects on these measures.  
The basis of the differential response of the COC and SAL groups to IDZ on 
these two measures (omission errors and nontrials) is somewhat unclear.   In the case 
of omission error rate, this issue is complicated in part by the fact that this measure 
appears to reflect multiple influences.  Based on numerous studies in our lab using this 
task or very similar ones, omission error rate reflects, at least in part, sustained 
attention. This inference is based on the findings that omission error rate increases as 
the cue duration decreases (Bayer, et al, 2000; Bayer, et al, 1994; Bayer and Strupp, 
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1995) and as the pre-stimulus delay increases (Bunsey and Strupp, 1995). Thus, a 
treatment difference in systems that modulate sustained attention is one possible 
candidate for the differential response of the COC and SAL groups to the IDZ effect 
on omission errors.  Another candidate is suggested by the present finding that 
omission error rate was significantly greater on trials following an incorrect response 
than on trials following a correct response.  Thus, the increased sensitivity of COC 
animals to IDZ on this measure may partially reflect prenatal cocaine-induced 
differences in emotional reactivity, specifically reactivity to errors.  This hypothesis is 
consistent with previous reports that prenatal cocaine exposure alters reactivity to 
errors in a very similar visual attention task (Morgan, et al, 1997; 2002), and in other 
situations, alters emotional reactivity, behavioral responses to stress, and arousal 
regulation (Bilitzke and Church, 1992; Church and Tilak, 1996; Dow-Edwards, et al, 
1999; Goldstein, et al, 1993; Johns and Noonan, 1995; Mayes, et al, 1998; Molina, et 
al, 1994; Murphy, et al, 1995; Wood, et al, 1994; Wood, et al, 1993; Wood, et al, 
1995).   A final possibility, although less likely, is that the increased sensitivity of the 
COC animals to the effects of IDZ on nontrials and omission errors reflects prenatal 
cocaine-induced differences in neural systems underlying motivation and/or response 
proclivity.  Increased omission errors and nontrials have been reported for 
manipulations that decrease response proclivity such as striatal lesions (Cole and 
Robbins, 1989), and those that decrease motivation such as increased food intake 
(Barnabe, unpublished data).  However, under the influence of IDZ in this study, 
subjects did not show a reduction in either premature response rate or in “pre-pokes” 
(nosepoke responses < 1 sec in duration that did not constitute a choice--data not 
presented), arguing against a decrease in response proclivity under the drug. 
The finding that the statistical interaction of IDZ and Prenatal Treatment was 
not seen for measures that tap selective attention, but was seen for omission errors and 
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nontrials, suggests that these latter effects may reflect different processes and 
underlying neural systems than the selective attention effects.  One interpretation that 
fits the pattern of findings is that the IDZ effect on commission errors is mediated by 
IDZ-induced increases in LC firing and thus increases in coeruleocortical NE activity 
(Aghajanian, et al, 1977; Dennis, et al, 1987), whereas the differential effect on 
omission errors and nontrials reflects a cocaine-induced alteration of norepinephrine-
modulated release of DA from the VTA and/or substantia nigra.  Alpha-2 adrenergic 
agents, like IDZ, have been shown to modulate dopamine release (Gresch, et al, 1995) 
by regulating the activity of the dopaminergic neurons in the ventral tegmental area 
and substantia nigra (Grenhoff and Svensson, 1988; Grenhoff and Svensson, 1989; 
Morrow, et al, 1996; Murphy, et al, 1996).  In fact, two lines of evidence suggest this 
interpretation.  First, the altered sensitivity to IDZ in cocaine-exposed rats was seen on 
errors of omission, but not errors of commission.  Based on our previous experience 
with this task, errors of omission in control rats have typically been modulated by 
drugs that specifically alter DA activity (Bayer, et al, 1994).  Second, for both 
measures on which a differential effect of IDZ was seen in the COC group (omission 
errors and nontrials) there was a suggestion that female rats were more sensitive than 
males to IDZ’s impairing effects.  In view of reports of increased dopaminergic 
activity in adult female rats relative to adult males (Bazzett and Becker, 1994; Castner 
and Becker, 1996; Castner, et al, 1993; Rivest, et al, 1995), this differential drug effect 
in the two sexes also supports a DA mechanism for the instances in which the two 
treatment groups responded differently to IDZ.  It is notable that, in contrast, male rats 
appeared to be more sensitive than females to IDZ’s effect on commission errors 
(inhibition errors and inaccurate responses). For inhibition errors, this was manifested 
as a shifting of the dose that produced impairment.  For inaccurate responses, IDZ 
impaired males and improved females, a pattern that also indicates greater sensitivity 
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of the males, in light of the evidence that (1) NE activity is higher in adult male rats 
than females (Babstock, et al, 1997; Borsody and Weiss, 1996; Heal, et al, 1989) and 
(2) NE modulates attention along an inverted U-shaped curve, with either suboptimal 
or supraoptimal NE levels producing attentional decrements.  In sum, the pattern of 
findings suggest that the commission error measures, on which the IDZ effect was 
similar in COC and control animals, reflect coeruleocortical NE activity, whereas 
those measures on which a differential treatment effect of IDZ was seen reflect NE-
modulated DA activity.   The altered IDZ response in the COC animals on these latter 
measures could reflect a lasting effect of the early drug exposure on the NE and/or the 
DA components of this system. Future studies are needed to answer this question.  
As noted in the Introduction, the available literature concerning the effects of 
prenatal cocaine exposure on central catecholaminergic activity does not present a 
clear picture.  This disparity is likely to be due, at least in part, to the wide variation in 
both doses of cocaine (ranging from 3 to 60 mg/kg), and routes of administration  (SC, 
PO, and IV) used in these studies (Dingell, 1993, Personal communication).  For this 
reason, we felt that it would be useful to ascertain the correspondence of the present 
findings specifically with those studies that utilized a comparable exposure regimen.  
Moreover, this IV exposure regimen may arguably provide data that is most relevant 
to the clinical situation being modeled, for several reasons.   First, the IV regimen 
most closely mimics the rapidly peaking pharmacokinetic profile seen following 
inhalation or IV injection of cocaine in humans. The 3.0 mg/kg dose utilized in the 
current study produces peak arterial plasma levels that are similar to those reported for 
humans administered 32 mg of cocaine IV (Booze, et al, 1997; Evans, et al, 1996). In 
addition, under experimental conditions, this dose is self-administered by “users” 
multiple times in a 2.5 hr session (Fischman and Schuster, 1982), and thus represents a 
low or recreational dose.  Finally, cocaine administration via the SC route of 
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administration, the most common regimen in prior studies, has been shown to cause 
skin irritation, increased corticosterone levels and adrenal enlargement in the dams (a 
sign of chronic stress), even with solutions as dilute as 40 mg/3 ml/kg (Dingell, 1993, 
Personal communication).  The fact that PO cocaine administration did not increase 
corticosterone levels or adrenal size in this same study (Dingell, 1993, Personal 
communication) suggests that these alterations were due to the dermal effects, not the 
cocaine per se.  Therefore, it is likely that administration of cocaine via the IV route, at 
a much lower dose (3 mg/kg), also avoids these adverse effects, since dermal irritation 
is not seen. However, comparable data for the IV route are not available.   
The studies that have used the IV route, with comparable cocaine doses, 
present a remarkably consistent picture, and indeed provide support for the present 
hypothesis that IDZ causes a greater DA response in COC rats than controls. These 
studies have shown that prenatal cocaine exposure does not alter basal DA levels or 
release (Wang, et al, 1995; Wang, et al, 1996), but does increase the DA response to a 
pharmacological challenge or stressor (Bayer, et al, 2000; Du, et al, 1999; Morrow, et 
al, 2001; Murphy, et al, 1995).  Alpha-2 adrenergic agents such as IDZ modulate 
stress-induced increases in DA turnover (Murphy, et al, 1996), suggesting that this 
differential dopaminergic response to stress seen following prenatal cocaine exposure 
may be due to lasting alterations in NE modulated DA release, consistent with the 
hypothesis put forward to explain the current results.   
This finding that the cocaine-exposed subjects are more sensitive to the effects 
of IDZ than controls has important functional implications.  Based on the evidence 
that stress and arousal increase endogenous levels of NE and DA (Horger and Roth, 
1996; Thierry, et al, 1976), these conditions may exacerbate the cognitive dysfunction 
seen in individuals exposed to cocaine.  This putative effect of prenatal cocaine on 
stress-induced impairment is consistent with reports of altered stress responses 
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following prenatal cocaine exposure (Bilitzke and Church, 1992; Campbell et al, 2000; 
Church and Tilak, 1996; Morrow, et al, 2001; Goldstein, et al, 1993; Goodwin, et al, 
1997; Johns and Noonan, 1995; Molina, et al, 1994; Murphy, et al, 1995; Wood, et al, 
1993; 1994; 1995).  The relatively small magnitude of these observed effects is not 
unexpected, given that the doses used in this study were selected to model 
“recreational” cocaine usage.  In fact, the magnitude of the group differences seen in 
this study were similar to those reported for 6-year old children exposed to cocaine in 
utero relative to controls (Richardson, et al, 1996). The relatively small magnitude of 
the observed effects is reassuring in light of the many children born each year with 
gestational exposure to this drug.  Nonetheless, one cannot rule out the possibility that 
this dysfunction, albeit selective and subtle, will significantly alter the lives of affected 
individuals.  For example, it has been estimated that a 5-point drop in IQ (comparable 
in magnitude to the group difference in omission errors observed here), results in a 
doubling of the number of children in the population diagnosed as mentally retarded 
(Rice, 1998).  Although the population distribution of attentional function is less well-
characterized than that for IQ, it is possible that that an attentional deficit of this 
magnitude might result in a similar increase in the risk of attention deficit disorder or 
related attentional disorders.  
It may be noted that, in the current study, effects of prenatal cocaine exposure 
were only seen under the influence of IDZ; i.e., not in the non-drug state.  However, 
prior findings from this same cohort of animals revealed that the COC animals were 
significantly impaired relative to controls in terms of both focused and selective 
attention (Morgan, et al, 1997).  A finding from this prior study may explain why 
attentional impairment was not seen in the COC animals in the present study.  
Specifically, the magnitude of the selective attention impairment decreased with 
increasing experience on the task. This finding suggests that the COC animals, 
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despite their attentional impairment, were eventually able to filter out these 
distracting cues with extensive training with the same set of distracting cues.  There is 
every reason to believe, however, that the greater distractibility of these COC animals 
would again become apparent if novel distractors were presented, or when tested in a 
novel task.   
The shape of the IDZ dose-effect curve also deserves comment.  For both 
commission and omission errors, an inverted-U shaped IDZ dose-response 
relationship was seen, with the greatest behavioral effect generally seen at the lowest 
dose.  This pattern likely reflects the fact that IDZ alters noradrenergic activity via 
both pre-synaptic and postsynaptic actions, since alpha-2 receptors (the drug’s 
binding site) are localized both pre- and post-synaptically (Aoki, et al, 1994; Aoki, et 
al, 1998; Venkatesan, et al, 1996).  IDZ blockade of presynaptic alpha-2 receptors 
increases NE release due to a reduction in NE-mediated negative feedback, whereas 
IDZ's blockade of postsynaptic alpha-2 receptors antagonizes the effects of released 
NE at synapses with post-junctional alpha-2 receptors.  It is possible that the 
inverted-U-shaped dose effect curve reflects a dose-related change in the ratio of 
binding to presynaptic vs. postsynaptic receptors. With regard to the commission 
error effects, it is hypothesized that the lower doses of IDZ impaired attention by 
blocking presynaptic receptors, thereby increasing NE activity beyond optimal levels; 
whereas higher doses of IDZ additionally caused blockade of post-synaptic alpha-2 
receptors, negating this effect.  Similarly, for the measures on which the COC group 
showed greater sensitivity to IDZ (i.e., the presumed NE-mediated DA effects), it is 
hypothesized that lowest dose of IDZ disrupted performance by its effect on 
presynaptic receptors, resulting in increased NE release and, consequently, increased 
DA release.  At higher doses, postsynaptic blockade antagonized the effects of the 
released NE, thus preventing the increase in DA release seen at lower doses.  This 
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hypothesis assumes that the post-synaptic adrenergic receptor mediating the increased 
DA release is the alpha-2 sub-type, an assumption that is consistent with the available 
evidence (Murphy, et al, 1996). 
In summary, the results of the current study suggest that prenatal cocaine 
exposure causes functionally significant changes in NE-modulated DA systems that 
persist into adulthood.  Based on the behavioral measures that showed a differential 
response to IDZ in the COC animals, it seems likely that these changes may 
contribute to the alterations in sustained attention and emotional reactivity that have 
been reported in both animals and humans exposed to cocaine in utero. 
 101 
REFERENCES 
 
Aghajanian CK, Cedarbaum JM, Wang RY (1977) Evidence for norepinephrine-
mediated collateral inhibition of locus coeruleus  neurons.  Brain Res 136: 570-577. 
 
Akbari HM, Azmitia EC (1992) Increased tyrosine hydroxylase immunoreactivity in 
the rat cortex following prenatal cocaine exposure. Dev Brain Res 66: 277-281. 
 
Aoki C, Go CG, Venkatesan C, and Kurose H (1994) Perikaryal and synaptic 
localization of alpha-2A-adrenergic receptor-like immunoreactivity. Brain Res 650: 
181-204. 
 
Aoki C,. Venkatesan C, Go CG, Forman R, Kurose H (1998) Cellular and subcellular 
sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed 
by the immunocytochemical localization of noradrenergic receptors and axons. 
Cerebral Cortex 8: 269-277. 
 
Arnsten AFT (1997)  Catecholamine regulation of the prefrontal cortex J 
Psychopharmacol 11:151-162. 
 
Arnsten AFT, Contant TA (1992) Alpha-2-adrenergic agonists decrease distractibility 
in monkeys performing the delayed response task.  Psychopharmacol 108: 159-169. 
 
Arnsten AFT, Steere JC, Hunt RD (1996) The contribution of alpha-2-noradrenergic 
mechanisms to prefrontal cortical cognitive function.  Arch Gen Psych 53: 448-455. 
 
Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and 
behavioral flexibility.  Biol Psych 46: 1309-1320. 
 
Aston-Jones G, Rajkowski J, Ivanova S, Usher M, Cohen J (1997) Neuromodulation 
and cognitive performance: Recent studies of noradrenergic locus ceruleus neurons in 
behaving monkeys. In: Advances in Pharmacology; Catecholamines: Bridging Basic 
Science With Clinical Medicine (Goldstein DS, Eisenhofer G, McCarty R, eds) pp. 
755-759. New York: Academic Press Inc.  
 
Aston-Jones G (1988) Cellular attributes of locus coeruleus:  implications for 
attentional processes  In: Progress in Catecholamine Research Part B:  Central Aspects 
(Dahlstrom A, Belmaker RH, Sandler M, eds) pp. 133-142. New York: Alan Liss Inc. 
 
Azuma SD, Chasnoff  IJ (1993) Outcome of children prenatally exposed to cocaine 
and other drugs: a path analysis of three-year data. Pediatrics 92: 396-402. 
 
Babstock D, Malsbury CW, Harley CW (1997) The dorsal locus coeruleus is larger in 
male than in female sprague-dawley rats. Neurosci Lett 224: 157-160. 
 
Bayer LE, Brown A, Mactutus CF, Booze RM, Strupp BJ (2000) Prenatal cocaine 
exposure increases senstivity to the attentional effects of the dopamine D1 agonist 
SKF81297. J Neurosci 20: 8902-8908. 
 
 102 
Bayer LE, Snow K, Strupp BJ (1994) Effect of SKF 81297 in control and lead-
exposed rats: evidence that D1 dopaminergic activity modulates attention. Soc 
Neurosci Abstr 20: 153. 
 
Bayer LE, Strupp BJ (1995) Effect of idazoxan (IDZ) in control and lead-exposed rats: 
Evidence for the role of norepinephrine (NE) in attention. Soc Neurosci Abstr 21: 
1231. 
 
Bazzett TJ, Becker JB (1994) Sex differences in the rapid and acute effects of estrogen 
on striatal d-2 dopamine receptor binding. Brain Res 637: 163-172. 
 
Beckwith L, Crawford S, Moore  JA, Howard J (1995) Attentional and social 
functioning of preschool-age children exposed to pcp and cocaine in utero.  In: 
Mothers, Babies, And Cocaine: The Role Of Toxins In Development (Lewis M, 
Bendersky M, eds) pp. 287-303. Mahwah NJ: Lawrence Erlbaum Associates. 
 
Bilitzke PJ, Church MW (1992) Prenatal cocaine and alcohol exposures affect rat 
behavior in a stress test. The porsolt swim test.  Neurotoxicol Teratol 14: 359-364. 
 
Booze RM, Lehner AF, Wallace DR, Welch MA, Mactutus CF (1997) Dose-response 
cocaine pharmacokinetics and metabolite profile following intravenous administration 
and arterial sampling in unanesthetized freely moving male rats. Neurotoxicol Teratol 
19: 7-15. 
 
Booze RM,  Wallace DR, Colson CL, Mactutus CF (1994)  Prenatal IV cocaine: 
Catecholamine innervation patterns and alpha-2 receptors in the rat hiocampus. Soc 
Neurosci Abstr 20: 597. 
 
Booze, RM (2000) personal communcation. 
 
Borsody MK, Weiss JM (1996) Influence of corticotropin-releasing hormone on 
electrophysiological activity of locus coeruleus neurons. Brain Res 724: 149-168. 
 
Bunsey MD, Strupp BJ (1995) Specific effects of idazoxan in a distraction task: 
evidence that endogenous norepinephrine plays a role in selective attention in rats. 
Behav Neurosci 109: 903-911. 
 
Bushnell PJ (1998) Behavioral approaches to the assessment of attention in animals. 
Psychopharmacol 138: 231-259. 
 
Bushnell PJ, Marrocco RT, Strupp BJ, Sarter MF, Levin ED, Warburton DM (2000) 
Attention as a Target of Intoxication: Insights and Methods from Studies of Drug 
Abuse.  Neurotoxicol Teratol 22: 487-502. 
 
Byrnes JJ, Pritchard GA, Koff JM, Miller LG (1993) Prenatal cocaine exposure: 
decreased sensitization to cocaine and decreased striatal dopamine transporter binding 
in offspring. Neuropharmacology 32: 721-723. 
 
Campbell JO, Bliven TD, Silveri MM, Snyder KJ, Spear LP (2000) Effects of prenatal 
cocaine on behavioural adaptation to chronic stress in adult rats.  Neurotoxicol Teratol 
22: 845-50. 
 
 103 
Castner SA, Becker JB (1996) Sex differences in the effect of amphetamine on 
immediate early gene expression in the rat dorsal striatum. Brain Res 712: 245-257. 
 
Castner SA,  Xiao L, Becker JB (1993) Sex differences in striatal dopamine: in vivo 
microdialysis and behavioral studies. Brain Res 610: 127-134. 
 
Church MW, Tilak JP (1996) Differential effects of prenatal cocaine and retinoic acid 
on activity level throughout day and night. Pharmacol Biochem Behav 55: 595-605. 
 
Clark CR, Geffen GM, Geffen LB (1987a) Catecholamines and attention I: Animal 
and clinical studies. Neurosci Biobehav Rev 11: 341-352. 
 
Clark CR, Geffen GM, Geffen LB (1987b) Catecholamines and attention II: 
Pharmacological studies in normal humans. Neurosci Biobehav Rev 11: 353-364. 
 
Cole BJ, Robbins TW (1989) Effects of 6-Hydroxydopamine lesions of the nucleus 
accumbens septi on performance of a 5-choice serial reaction time task in rats:  
Implications for theories of selective attention and arousal.  Behav Brain Res 33: 165-
179. 
 
Cutler AR, Wilkerson AE, Gingras JL, Levin ED (1996) Prenatal cocaine and/or 
nicotine exposure in rats: preliminary findings on long-term cognitive outcome and 
genital development at birth. Neurotoxicol Teratol 18: 635-643. 
 
Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2 adrenoceptors 
play a major role in the effect of idazoxan on cortical noradrenaline release as 
measured by in-vivo dialysis in the rat.  J Pharmacol Exp Ther 241: 642-649. 
 
Dingell JW (1993) Personal communication, NIDA, DBR, March 11, 1993. 
 
Dow-Edwards D,  Mayes L,  Spear L, Hurd Y (1999) Cocaine and development: 
Clinical, behavioral, and neurobiological perspectives-A symposium report. 
Neurotoxicol Teratol 21: 481-490. 
 
Du W, Aloyo VJ, Pazdelski PS, Harvey JA (1999) Effects of prenatal cocaine 
exposure on amphetamine-induced dopamine release in the caudate nucleus of the 
adult rabbit. Brain Res 836: 194-198. 
 
Evans SM, Cone EJ, Henningfield JE (1996) Arterial and venous cocaine plasma 
concentrations in humans. Relationship to route of administration, cardiovascular 
effects, and subjective effects. J Pharmacol Exp Therap 279: 1345-1356. 
 
 Fischman MW, Schuster CR (1982) Cocaine self administration in humans.  64th 
Annual Meeting of The Federation of American Societies for Experimental Biology, 
Anaheim, CA, April 17, 1980. Fed Proc 41: 241-246. 
 
Gabriel M, Taylor C (1998) Prenatal exposure to cocaine impairs neuronal coding of 
attention and discriminative learning. In: Cocaine: Effects On The Developing Brain 
(Harvey JA, Kosofsky BE, eds) Annals Of The New York Academy Of Sciences 846, 
pp. 194-212. New York:  New York Academy Of Sciences. 
 
 104 
Garavan H, Morgan RE, Mactutus CF, Levitsky DA, Booze RM, Strupp BJ (2000) 
Impaired selective attention in rats exposed to cocaine prenatally: Evidence from 
extra-dimensional shift and serial reversal tasks.  Behav Neurosci 114: 725-738. 
 
Goldstein LE, Murphy BL, Roth RH (1993) Effects of prenatal cocaine exposure on 
stress-induced behaviors. Faseb Journal 7: A856. 
 
Goodwin GA, Bliven T,  Kuhn C,  Francis R, Spear LP (1997) Immediate early gene 
expression to examine neuronal activity following acute and chronic stressors in rat 
pups: Examination of neurophysiological alterations underlying behavioral 
consequences of prenatal cocaine exposure. Physiol Behav 61: 895-902. 
 
Grenhoff J, Svensson TH (1988) Clonidine regularizes substantia nigra dopamine cell 
firing. Life Sci 42: 2003-2010. 
 
Grenhoff J, Svensson TH (1989) Clonidine modulates dopamine cell firing in rat 
ventral tegmental area. Eur J Pharmacol 165: 11-18. 
 
Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous 
norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 
65: 111-116. 
 
Heal DJ, Bristow LM, Hurst EM, Elliott JM, Buckett WR (1989) Sex-related 
differences in central adrenergic function and responsiveness to repeated 
administration of desipramine or electroconvulsive shock. Br J Pharmacol 97: 111-
118. 
 
Henderson MG, Mcconnaughey MM, Mcmillen BA (1991) Long-term consequences 
of prenatal exposure to cocaine or related drugs effects on rat brain monoaminergic 
receptors.  Brain Res Bull 26: 941-946. 
 
Horger BA, Roth RH (1996) The role of mesoprefrontal dopamine neurons in stress. 
Crit Rev Neurobiol 10: 395-418. 
 
Johns JM, Noonan LR (1995) Prenatal cocaine exposure affects social behavior in 
Sprague-Dawley rats. Neurotoxicol Teratol 17: 569-576. 
 
Karmel BZ, Gardner JM (1996) Prenatal cocaine exposure. Effects on arousal-
modulated attention during the neonatal period developmental. Psychobiology 29: 
463-480. 
 
Kunko PM, Wallace MJ, Robinson SE (1996) Gestational cocaine and ethanol 
exposure alter spontaneous and cocaine-induced behavior in weanling rats. Pharmacol 
Biochem Behav 55: 559-564. 
 
Leech SL, Richardson GA, Goldschmidt L, Day NL (1999) Prenatal substance 
exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol 21: 
109-118. 
 
Mactutus CF (1999) Prenatal intravenous cocaine adversely affects attentional 
processing in preweanling rats. Neurotoxicol Teratol 21: 539-50. 
 
 105 
Mactutus CF, Herman AS, Booze RM (1994) Chronic intravenous model for studies 
of drug (ab)use in the pregnant and/or group-housed rat: An initial study with cocaine. 
Neurotoxicol Teratol 16: 183-191. 
 
Marrocco RT, Davidson MC (1998) Neurochemistry of Attention. In: The Attentive 
Brain (Parasuraman, R ed) pp. 35-50. Cambridge, MA:  MIT press. 
 
Mayes LC, Grillon C, Granger R, Schottenfeld R (1998) Regulation of arousal and 
attention in preschool children exposed to cocaine prenatally. Annals of the New York 
Academy of Sciences 846: 126-143. 
 
Meyer JS, Dupont SA (1993) Prenatal cocaine administration stimulates fetal brain 
tyrosine hydroxylase activity. Brain Res 608: 129-137. 
 
Meyer JS, Sherlock JD, Macdonald NR (1992) Effects of prenatal cocaine on 
behavioral responses to a cocaine challenge on postnatal day 11. Neurotoxicol Teratol 
14: 183-189. 
 
Molina VA, Wagner JM, Spear LP (1994) The behavioral response to stress is altered 
in adult rats exposed prenatally to cocaine. Physiol Behav 55:941-945. 
 
Morgan RE, Garavan H, Mactutus CF, Booze  RM, Strupp BJ (2002) Enduring effects 
of prenatal cocaine exposure on attention and reaction to errors.  Behav Neurosci 
116(4): 624-633. 
 
Morgan RE, Garavan H, Mactutus CF, Booze  RM, Strupp BJ (1997) Prenatal cocaine 
exposure: enduring effects on sustained and selective attention.  Neurotox Teratol 19: 
249. 
 
Morrow BA, Elsworth JD, Roth RH (2001) Prenatal exposure to cocaine reduces the 
number and enhances reactivity of A10 dopaminergic neurons to environmental stress. 
Synapse 41: 337-344.  
 
Morrow BA, George TP, Lee EJK, Roth RH (1996) Noradrenergic alpha-2 agonists 
diminish behavioral and dopaminergic responses to conditioned fear. Soc Neurosci 
Abstr 22: 2063. 
 
Murphy BL, Arnsten AFT, Jentsch JD, Roth RH (1996) Dopamine and spatial 
working memory in rats and monkeys: Pharmacological reversal of stress-induced 
impairment. J Neurosci 16: 7768-7775. 
 
Murphy BL, Heffelfinger RN, Roth RH (1995) Rats exposed prenatally to cocaine 
show heightened fg 7142-induced deficits on a delayed alternation task. Society For 
Neuroscience Abstracts 21: 707. 
 
Peris J, Coleman-Hardee M, Millard WJ (1992) Cocaine in-utero enhances the 
behavioral response to cocaine in adult rats. Pharmacol Biochem Behav 42: 509-515. 
 
Rice, DC (1998) Issues in developmental neurotoxicology:  Interpretation and 
implications of the data. Can J Pub Health 89: S31-S36. 
 
 106 
Richardson GA, Conroy ML, Day NL (1996) Prenatal cocaine exposure: effects on the 
development of school-age children. Neurotoxicol Teratol 18: 627-634. 
 
Rivest R, Falardeau P, DiPaolo T (1995) Brain dopamine transporter: Gender 
differences and effect of chronic haloperidol. Brain Res 692: 269-272. 
 
Robbins TW (1997) Arousal systems and attentional processes. Biol Psychol 45: 57-
71. 
 
Robbins TW, Everitt BJ, Cole BJ, Archer T, Mohammed A (1985) Functional 
hypotheses of the coeruleocortical noradrenergic projection:  A review of recent 
experimentation and theory. Physiol Psych 13: 127-150. 
 
Robinson SE, Enters EK, Jackson GF, Chinchilli VM, Maher JR, McDowell KP, 
Allen HM, Guo H (1994) Maternal and fetal brain and plasma levels of cocaine and 
benzoylecgonine after acute or chronic maternal intravenous administration of 
cocaine.  J Pharmacol Exp Ther 271: 1234-1239. 
 
Romano AG, Harvey JA (1996) Prenatal exposure to cocaine disrupts discrimination 
learning in adult rabbits. Pharmacol Biochem Behav 53: 617-621. 
 
Sara SJ (1985) Noradrenergic modulation of selective attention its role in memory 
retrieval.  Annals Of The New York Academy Of Science 444: 178-193. 
 
Sara SJ, Devauges V, Sega M (1988) Locus coeruleus engagement in memory 
retrieval and attention. In: Progress in Catecholamine Research Part B:  Central 
Aspects (Dahlstrom A, Belmaker RH, and Sandler M, eds) pp. 155-161. New York: 
Alan Liss Inc. 
 
Seidler FJ, Slotkin TA (1992) Fetal cocaine exposure causes persistent noradrenergic 
hyperactivity in rat brain regions: Effects on neurotransmitter turnover and receptors. J 
Pharmacol Exp Therap 263: 413-421. 
 
Simansky KJ, Kachelries WJ (1996) Prenatal exposure to cocaine selectively disrupts 
motor responding to d-amphetamine in young and mature rabbits.  
Neuropharmacology 35: 71-78. 
 
Strupp BJ,  Morgan RE, Garavan H, Mactutus CF, Booze RM (1998) Prenatal cocaine 
exposure: An emerging cognitive profile. Neurotoxicol Teratol 20: 355. 
 
Thierry AM, Tassin, JP, Blanc, G, Glowinski, J (1976) Selective activation of the 
mesocortical DA system by stress.  Nature 263: 242-244. 
 
Vathy I, Katay L, Mini KN (1993) Sexually dimorphic effects of prenatal cocaine on 
adult sexual behavior and brain catecholamines in rats. Develop Brain Res 73: 115-
122. 
 
Venkatesan C, Song XZ, Go CG, Kurose H, Aoki C (1996) Cellular and subcellular 
distribution of alpha-2A-adrenergic receptors in the visual cortex of neonatal and adult 
rats. J Comp Neur 365: 79-95. 
 
 107 
Wallace DR,  Mactutus CF, Booze RM (1996) Prenatal iv cocaine produces persistent 
alterations in hippocampal alpha-2-adrenergic receptor density and function. Soc 
Neurosci Abstr 22: 1885. 
 
Wang HY, Yeung JM, Friedman E. (1995) Prenatal cocaine exposure selectively 
reduces mesocortical dopamine release. J Pharmacol Exp Therap 273: 1211-1215. 
 
Wang XH, Levitt P, Jenkins AO, Murphy EH (1996) Normal development of tyrosine 
hydroxylase and serotonin immunoreactive fibers innervating anterior cingulate cortex 
and visual cortex in rabbits exposed prenatally to cocaine. Brain Res 715: 221-224. 
 
Wood RD, Bannoura MD, Johanson IB (1994) Prenatal cocaine exposure: Effects of 
play behavior in the juvenile rat. Neurotoxicol Teratol 16: 139-144. 
 
Wood RD, Molina VA, Wagner JM, Spear LP (1993) Prenatal exposure to cocaine 
alters later responsiveness to an uncontrollable stressor in periadolescent as well as 
adult rats. Soc Neurosci Abstr 19: 1854. 
 
Wood RD, Molina VA, Wagner JM, Spear LP (1995) Play behavior and stress 
responsivity in periadolescent offspring exposed prenatally to cocaine. Pharmacol 
Biochem Behav 52: 367-374.  
 108 
CHAPTER 4 
 
PRENATAL COCAINE EXPOSURE INCREASES SENSTIVITY TO THE 
ATTENTIONAL EFFECTS OF THE DOPAMINE D1 AGONIST SKF81297∗  
 
ABSTRACT 
 
Sensitivity to the attentional effects of SKF81297, a selective full agonist at 
DA D1 receptors, was assessed in adult rats exposed to cocaine prenatally (via IV 
injections) and controls. The task assessed the ability of the subjects to monitor an 
unpredictable light cue of either 300 or 700 msec duration, and maintain performance 
when presented with olfactory distractors. SKF81297 decreased nose-pokes prior to 
cue presentation, as well as increased latencies and response biases (the tendency to 
respond to the same port as on the previous trial), suggesting an effect of SKF81297 
on DA systems responsible for response initiation and selection. The COC and control 
animals did not differ in sensitivity to the effects of SKF81297 on these measures. In 
contrast, the COC animals were significantly more sensitive than controls to the 
impairing effect of SKF81297 on omission errors, a measure of sustained attention. 
This pattern of results provides evidence that prenatal cocaine exposure produces 
lasting changes in the DA system(s) subserving sustained attention but does not alter 
the DA system(s) underlying response selection and initiation. These findings also 
provide evidence for the role of D1 receptor activation in attentional functioning. 
                                                
∗ Bayer LE, Brown A, Mactutus CF, Booze RM, and Strupp BJ  (2000) Prenatal 
Cocaine Exposure Increases Sensitivity to the Attentional Effects of the Dopamine D1 
Agonist SKF81297.  Journal of Neuroscience 20(23):  8902-8908. 
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INTRODUCTION 
 
Concern about effects of prenatal cocaine exposure has grown in recent years. 
Although early media reports of gross neurological sequelae have proven largely 
unfounded, recent controlled studies have revealed attentional dysfunction in exposed 
children that persists into school age years (Dow-Edwards, et al, 1999; Leech, et al, 
1999; Mayes, et al, 1998; Richardson, et al, 1996).  Because maternal cocaine use in 
these studies generally occurred within the context of multiple risk factors, including 
polydrug abuse, it is important that animal model studies have demonstrated a clear 
causal link between prenatal cocaine exposure and attentional dysfunction (Garavan, 
et al, 2000; Mactutus, 1999; Morgan, et al, 1997; Romano & Harvey, 1996; Wilkins, 
et al, 1998a; 1998b).  Elucidation of the neural bases of these deficits might allow 
amelioration or reversal of the dysfunction.  This goal motivated the present study. 
Altered dopaminergic (DA) activity, particularly in prefrontal and anterior 
cingulate cortices, is one mechanism that may underlie prenatal cocaine-induced 
attentional deficits.  Moderate DA activity is critical for optimal functioning of frontal 
cortical regions (reviewed in Arnsten, 1997; Robbins, et al, 1994), thought to subserve 
attentional functions impaired by cocaine exposure (reviewed in Arnsten, et al, 1994; 
Arnsten, 1997; Carter, et al, 1997; Coull, 1998; Garavan, et al, 2000; Posner & 
Rothbart, 1998).  Prenatal cocaine exposure has been reported to disrupt CNS DA 
function, (reviewed in Mayes 1999).  However, definitive conclusions about the role 
of DA alterations in prenatal cocaine-induced attentional dysfunction cannot be drawn 
for several reasons. First, both the presence and direction of cocaine-induced 
alterations have been inconsistent across studies.  Second, most studies administered 
cocaine via subcutaneous injections, which often cause necrotic skin lesions in 
cocaine-exposed dams (Bruckner, et al, 1982).  Therefore, the extent to which reported 
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changes are due to maternal stress rather than, or in addition to, cocaine exposure is 
unknown. A final limitation is the absence of direct links between DA systems and 
attentional dysfunction.  
The present study was designed to test the hypothesis that altered activity at D1 
receptors contributes to lasting attentional dysfunction in prenatal cocaine-exposed 
animals.  Adult IV cocaine-exposed and control rats were administered SKF81297, a 
selective, full, D1 agonist, prior to testing on an attentional task.  Attentional effects of 
SKF81297 in control subjects were interpreted as supporting a role for D1 receptor 
mechanisms in attention.  Altered sensitivity to the attentional effects of SKF81297 in 
cocaine-exposed subjects was considered indicative of enduring alterations in DA 
systems subserving attention.  
 
METHODS 
 
Subjects 
Nulliparous Long Evans rats (Harlan Sprague Dawley, Indianapolis, IN), 
approximately 11 weeks old, were housed in AAALAC-accredited animal facilities 
maintained at 21 ± 2°C, 50% ± 10% relative humidity with a 12 hour light:12 hour 
dark  cycle. Food (Pro-Lab Rat, Mouse, Hamster Chow No. 3000) and water were 
available ad libitum. Subjects were randomly assigned to either receive a surgical 
catheterization procedure (described below) or to serve as unoperated surrogate 
controls.  Following surgery, subjects in the catheterization group were randomly 
assigned to receive either cocaine or saline (vehicle control).  This research protocol 
was approved by the animal care review boards of the University of Kentucky and 
Cornell University. 
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Catheterization 
Subjects in the catheterization group were surgically implanted with a sterile 
IV catheter (described in detail in Mactutus, et al, 1994).  Briefly, one week prior to 
mating, subjects were anesthetized with a mixture of ketamine hydrochloride (100 
mg/kg/ml) and xylazine (3.3 mg/kg/ml) administered IP.  A sterile Intercath IV 
catheter (22 gauge, Becton/Dickson) with a Luer-lock injection cap (Medex) was cut 
to a length of ~8 cm and implanted subcutaneously (SC).  The distal end of the 
catheter was inserted into the jugular vein and threaded centrally.  The proximal end 
of the catheter, including the injection cap, was left as a small SC pouch on the dorsal 
surface of the animal through which chronic IV injections were made.  Catheter 
patency was maintained by daily flushing with 0.2 ml of heparinized saline (2.5%). 
 
Mating 
After recovery from surgery (4-8 days) the females were group-housed (n=3) 
with a male rat.  Daily vaginal lavage of each female was performed to keep track of 
estrous cycles and to assist in defining conception. Conception (gestational day 0, or 
GD0) was confirmed by a sperm-positive lavage.   
 
IV Drug Injection 
IV drug administration procedures were conducted as described in Mactutus, 
et al. (1994).  Briefly, all dams received daily IV saline injections (1ml/kg) from 
conception until gestational day (GD) 7.  Dams in the saline subgroup (n=8) 
continued to receive IV saline injections once per day from GD8-14 and twice daily 
from GD15-21.  Dams in the cocaine subgroup (n=8) received cocaine hydrochloride 
(3.0mg/ 1ml /kg, IV; Research Triangle Institute, NC) once per day from GD8-14 and 
twice daily from GD15-21.  The drug was dissolved immediately prior to injection.   
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This IV injection procedure mimics the rapidly peaking pharmacokinetic 
profile following inhalation or IV injection of cocaine in humans. The 3.0 mg/kg dose 
produces peak arterial plasma levels that are similar to those reported for humans 
administered 32 mg of cocaine IV (Booze, et al, 1997; Evans, et al, 1996). Under 
experimental conditions, this dose is self-administered by “users” multiple times in a 
2.5 hr session (Fischman & Schuster, 1982), and thus represents a low or recreational 
dose, highly relevant to the clinical situation being modeled.  This regimen (route, 
dose, and rate) produces no evidence of overt maternal or fetal toxicity, no maternal 
seizure activity, no effect on maternal weight, and no effect on offspring growth or 
mortality (e.g., Mactutus, 1999; Mactutus, et al, 1994).  Furthermore, this IV injection 
procedure does not reduce food intake of dams even when utilizing a cocaine dose as 
high as 6 mg/kg (S. Robinson, unpublished observations), precluding the need for 
pair-fed controls. 
 
Offspring treatment 
All cocaine-exposed and saline-exposed offspring used during this study were 
generated simultaneously.  Within 24 hours of birth, pups were weighed, culled to 4 
males and 4 females per litter (when possible), and fostered to a surrogate dam who 
had given birth within the preceding 24 hours.  Fostering was conducted for both 
cocaine (COC) and saline-exposed (SAL) offspring in order to limit the effects of the 
maternal drug treatment to the prenatal period; i.e., potential effects of gestational 
cocaine treatment on maternal behavior were removed as a source of offspring 
differences.  
On postnatal day 21 (PND21), pups were weaned and earpunched for 
identification.  Within 10 days of weaning, one male and one female offspring from 
each litter were shipped under environmentally-controlled conditions from 
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Lexington, KY to Ithaca, NY (Cornell University).  Upon arrival, subjects were 
housed in same sex pairs on a reversed dark/light cycle and allowed to acclimate to 
the new environment for 2-3 weeks.  Training/ behavioral testing began for all 
animals on PND48.  All personnel handling and testing the animals were blind to 
their treatment conditions. Offspring tested in the current study included 15 COC (8 
male, 7 female) and 15 SAL (7 male, 8 female) animals.  The animals were 
approximately 160 days of age at the beginning of the present study. 
 
Behavioral testing 
Apparatus 
Testing was conducted in 10 automated Plexiglas chambers enclosed in 
sound-attenuating wooden boxes, each operated by an IBM PC XT.  Each chamber 
consisted of a square waiting area (26.5 cm by 25 cm by 30 cm), adjacent to a testing 
alcove containing 3 funnel-shaped ports.  An LED was mounted above each port.  A 
thin metal door, raised at the initiation of each trial, separated these two 
compartments. The left and right ports were 8 cm apart, each at an approximate 45º 
angle relative to the center port.  Each port was connected by tubing to three bottles 
containing liquid odorants, attached to a board placed outside of the wooden 
enclosure.  Solenoid valves controlled the presentation of compressed air, pumped 
through a specific odorant and through a specific port.  The airflow rate was 1.0 
L/min and the air in the chamber was cleared via small centrifugal fans mounted on 
the outside of the chambers, at a rate of four complete exchanges per minute. A set of 
infrared phototransistors and a light source monitored the entrance to the alcove and 
each port.  A one second nose-poke into one of the three ports indicated a response.  
Correct responses were reinforced with a 45 mg food pellet (Noyes, Lancaster, NH) 
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delivered into the alcove from a pellet dispenser (Lafayette Instrument Co., Lafayette, 
IN). 
 
Training procedure  
As part of a previous experiment (Morgan, et al, 1997), subjects were first 
trained to make a 1-sec nose-poke into a port to receive a reward pellet.  Subjects 
were then trained on a series of consecutive attention tasks: 1) a three-choice visual 
discrimination in which subjects were rewarded for responding to the port under the 
illuminated LED; 2) a series of vigilance tasks in which the delay before cue onset 
varied as did the duration of the light cue; and 3) a variant of the distraction task 
described below. Subjects were maintained on a restricted feeding schedule 
(approximately 18 g/day for females, 21 g/day for males) to motivate the animals to 
perform the task.   
 
Distraction Task 
Prior to initiation of the SKF81297 challenge study, subjects received an 
additional 12 days of testing on the distraction task to achieve a stable baseline 
performance level for each rat.  In this task, the opening of the alcove door signaled 
the onset of each trial.  After the subject entered the testing alcove, one of the three 
LEDs was briefly illuminated (the discriminative stimulus).  A 1-sec nose-poke into 
the port under the illuminated light was deemed correct and resulted in delivery of a 
45 mg Noyes pellet. Several parameters were randomly varied across the trials in 
each session:  1) the pre-stimulus delay (2 or 3 sec after alcove entry); 2) duration of 
the light cue (300 or 700 msec); 3) presentation of an olfactory distractor.  On 1/3 of 
the trials in each session, one of nine different odors was delivered randomly through 
one of the ports (i.e., it could emanate from the correct or incorrect ports), either one 
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or two sec prior to visual cue onset.  No odors were presented on the remaining third 
of the daily trials (nondistraction trials).  The pre-stimulus delay, cue duration, cue 
location, and distraction condition for each trial were selected pseudorandomly, 
balanced for each session.  A correct response (defined above) resulted in delivery of 
a food pellet and ended the trial, signaled by the closing of the alcove door.  Incorrect 
responses included: (1) a 1-sec nose-poke into any port prior to the light cue onset 
(premature response), (2) a 1-sec nose-poke into an incorrect port following cue 
presentation (an inaccurate response), and (3) entering the alcove but failing to 
respond within 15 sec of trial onset (an omission error).  Each of these incorrect 
responses also terminated the trial, but with no reinforcement.  If the animal failed to 
enter the alcove within 30 sec after the door was raised, the alcove door closed and a 
nontrial was recorded.  An intertrial interval of 5 sec was imposed between 
successive trials.  A variant of this task had previously revealed enduring effects of 
prenatal cocaine exposure on selective attention in this cohort of animals (Morgan, et 
al, 1997). 
 
Response types  
Means for percentage correct, alcove and response latencies, and nontrials 
were calculated for each session.  In addition, means for the following error types 
were calculated: premature responses, inaccurate responses, and omission errors.  
Also analyzed were (1) response bias, the tendency to respond to the same port as on 
the previous trial; and (2) prepokes, defined as nose-pokes of less than one second 
that did not constitute a choice. 
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SKF81297 challenge study 
Daily sessions consisted of 100 trials or 60 minutes, whichever came first.  
Each animal received three test sessions per week (Monday, Wednesday, and Friday). 
All 30 subjects were tested on each testing day, using three sequential 1-hr shifts 
(12:30, 1:30, and 2:30 PM), each containing 10 subjects.  Prenatal treatment was 
balanced across shift and testing chamber (n=10).   SKF81297 (0.03, 0.1, 0.3 mg/kg; 
Research Biochemicals, Inc, Natick MA) or vehicle control was administered 
subcutaneously 15 minutes prior to testing.  SC administration was utilized to 
minimize injection stress.  The time-course of the effects of SKF81297 on behavior 
following this route of administration has been well established (Gerlach and Hansen, 
1993; Lublin, et al, 1992; 1993; 1994).  Each subject received each of the 4 doses 5 
times, with dose order determined by a Latin Square design.  Successive injection 
days were separated by a minimum of 48 hrs to allow drug clearance.   
 
Statistical Analysis 
Data were analyzed using the SAS version 6.11 PROC MIXED mixed models 
analysis of variance procedure which uses maximum likelihood estimation to account 
appropriately for the correlated structure within repeated measures designs.  To 
normalize the distributions, an arcsin square-root transformation was applied to the 
percentage correct, percentage premature errors, percentage omission errors, and 
percentage accuracy data.  Percentage correct was analyzed as a function of Prenatal 
Treatment, Sex, SKF81297 Dose, Pre-stimulus Delay, Cue Duration, Distraction 
condition (no distractor, distractor 1 sec before cue, distractor 2 sec before cue), and 
the relevant interactions of these variables.  Prenatal treatment and Sex were included 
as between-subjects variables, SKF81297 dose was included as a within-subject 
variable, and Delay, Duration, and Distraction were included as within-subject, 
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within-session variables.  Similar analyses were conducted on the specific error types: 
percentage omission errors, percentage accuracy errors, and percentage premature 
responses.  
Similar analyses were conducted on prepokes.   Two types of prepokes were 
distinguished: those prepokes that occurred before the light cue (early) and those that 
occurred after the cue (late).  The former were considered indicative of impulsivity 
whereas the latter were thought to reflect decision-making processes.  
Effects on motivation level were assessed by analyses of nontrials and alcove 
latency.  To normalize the distribution, alcove latencies were natural log transformed 
prior to analysis, and then analyzed as a function of Prenatal Treatment, Sex, 
SKF81297 dose, correctness on the previous trial and the relevant interactions of 
these variables. Nontrials were analyzed as a function of Prenatal Treatment, Sex, 
SKF81297 dose, and the relevant interactions of these variables. 
Similar analyses were conducted on mean response latency.  Separate 
analyses were conducted on those response latencies that occurred on correct trials 
vs. those that occurred on incorrect trials.  The former were considered to reflect 
information processing speed whereas the latter provide insight into the types of 
errors committed. 
Response bias was analyzed as a function of Prenatal Treatment, Sex, 
SKF81297 dose, Pre-stimulus Delay, Light Cue Duration, Distraction Condition, 
correctness of the previous trial, and the relevant interactions of these variables.  
 
RESULTS 
 
For all figures of percentage correct and percentage error-type data, least 
squares means (and associated standard errors) of transformed data are presented 
 118 
rather than raw geometric means because they more accurately reflect the results of 
the statistical analyses. 
 
Maternal/litter effects 
Prenatal cocaine treatment did not alter maternal weight gain during gestation, 
measured on GD 0, 8, 15, and 21 [F(1,16) = 0.00, p < 0.98]; gestation length [F(1,15) 
= 0.01, p < 0.93]; pup birthweight [F(1,16) = 0.44, p < 0.52]; litter sex ratio [F(1,14) = 
0.66, p < 0.43], or litter size [F(1,16) = 0.01, p < 0.92].   
 
Percentage Correct 
Percentage correct for a given session was calculated as the percentage of 
trials in the session on which the correct response was made within 10 seconds of 
trial onset.  Percentage correct was lowest under conditions of greatest attentional 
demand:  300 ms light cue condition [Duration:  F(1,1285)=300.81, p≤0.0001], trials 
with distractors [Distraction condition: F(2,1285)=24.78, p≤0.0001],  and 3 sec pre-
stimulus delay [Delay:  F(1,1285)=14.69, p≤0.0001].  Prenatal cocaine exposure did 
not alter overall percentage correct [F(1,27)=0.00, p≤0.9916], nor was there a 
Prenatal Treatment by SKF81297 interaction on this measure [F(3,81)=0.86, 
p≤0.4634].  SKF81297 decreased percentage correct [F(3,81)=24.58, p≤0.0001], 
specifically at the highest dose (vehicle vs. high dose: p≤0.0001); the two lower doses 
of SKF81297 did not significantly alter this response type.   As seen in Fig. 4.1, the 
magnitude of this drug-induced impairment was greatest on trials when a distractor 
was presented 1 sec prior to presentation of the shorter cue [SKF*cue 
duration*distraction: F(6,1285)=2.42, p≤0.0249]. 
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Figure 4.1.  Effect of SKF81297 on overall percent correct.  The highest dose of 
SKF81297 decreased percentage correct (high dose vs vehicle: p≤0.0001). To simplify 
the figure, only the vehicle and 0.3 mg/kg dose are included, as this highest dose is the 
only one at which a significant drug effect was seen.  The magnitude of this 
impairment was greatest under the 300 msec cue and “-1” distractor condition 
(SKF*cue duration*distraction, p≤0.0249). See results for details. (1.01 and 1.24 on 
this scale correspond to 72 and 89% respectively.) 
 
Inaccurate Responses 
Inaccurate responses were calculated as the percentage of trials in the session 
in which an incorrect port was chosen after light cue offset, within 10 sec of trial 
onset.  The rate of inaccurate responses was highest under conditions of greatest 
attentional demand: trials with the 300 ms light cue [Duration:  F(1,1294)= 347.24, 
p≤0.0001], and trials with distractors [Distraction condition: F(2,1294)=13.90, 
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p≤0.0001].  This measure was not affected by Prenatal cocaine exposure 
[F(1,26)=0.08, p≤0.7851], SKF81297 dose [F(3,81)=0.65, p≤0.5821], nor the 
interaction of these variables [F(3,81)=0.46, p≤0.7129].  
 
Premature Responses 
Premature responses were calculated as the percentage of trials in the session 
on which the subject made a response prior to light cue presentation.  To reduce the 
proportion of zeros in the dataset, it was necessary to average data across cue 
duration and timing of distractor onset (“-1” vs “-2” distractor conditions).   
Prenatal cocaine treatment did not alter premature response rate 
[F(1,27)=0.10, p≤0.7498], nor was there an interaction of Prenatal Treatment and 
SKF81297 dose [F(3,84=1.41, p≤0.2450].  There was a significant effect of 
SKF81297 on premature response rate [F(3,84)=3.35  0.0228], reflecting the fact that 
the highest dose of SKF81297 significantly decreased premature responses (vehicle 
vs high: p≤0.0255), a tendency also seen at the medium dose (vehicle vs medium: 
p≤0.0894) (see figure 3.2). In addition, females made more premature responses than 
males [F(1,27)=6.36, p≤0.0179]. 
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Figure 4.2.   Effect of SKF81297 on premature responses.   SKF81297 decreased the 
overall premature response rate  (p≤0.0228),  specifically at the highest dose (vehicle 
vs high: dose  p<0.0255).  See results for details.  (0.14 and 0.17 on this scale 
correspond to 1.9 and 2.9 % respectively.) 
 
Omission errors 
Percentage of omission errors was calculated as the percentage of trials in the 
session on which the subject entered the testing alcove but failed to respond within 15 
sec of trial onset. These errors were considered indicative of lapses of attention.  In 
order to reduce the proportion of zeros on this measure in the dataset, it was 
necessary to average data across Pre-stimulus Delay and Timing of distractor onset 
(“-1” vs “-2” distractor conditions).  The rate of omission errors was higher on trials 
with the 300 ms cue than on those with the 700 msec cue [Duration:  F(1,348)= 
49.32, p≤0.0001], consistent with the interpretation that omission errors reflect lapses 
in attention. 
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There was no main effect of Prenatal Treatment on omission error rate [F(1, 
26)= 0.36, p≤0.5534].  In contrast, SKF81297 increased omission errors [SKF: F(3, 
81)=57.49, p≤ 0.0001], specifically at the two highest doses (vehicle vs medium: 
p≤0.0456; vehicle vs high:  p≤0.0001). In addition, COC rats were more sensitive 
than controls to SKF81297’s impairing effect on this measure [COC*SKF: 
F(3,81)=2.75, p≤0.0481], exhibiting impairment at a lower dose of SKF81297 than 
SAL rats.  COC rats were impaired by the 0.1 mg/kg dose of SKF81297 (vehicle vs 
0.1mg/kg for COC: p≤0.0035) whereas SAL rats were not impaired by this dose 
(vehicle vs 0.1mg/kg for SAL:  p≤0.8889). There was a tendency for the two groups 
to differ in omission error rate at this dose but the contrast did not achieve statistical 
significance (p <0.1116). The 0.3 mg/kg dose of SKF81297 impaired both the COC 
(vehicle vs 0.3mg/kg for COC: p≤0.0001) and the SAL groups (vehicle vs 0.3 mg/kg 
for SAL: p≤0.0001), and the two groups did not differ in omission error rate at this 
dose (p <0.4144). The groups did not differ in the vehicle condition (p≤0.9981; see 
figure 4.3).  
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Figure 4.3.  COC rats showed increased sensitivity to SKF81297s impairing effect on 
omission errors. COC rats were more sensitive than SAL rats to SKF81297’s effect on 
omission errors (COC*SKF: p≤0.0481), showing impairment at a lower dose of 
SKF81297 than SAL rats (vehicle vs 0.1mg/kg for COC, p≤0.0035; vehicle vs 
0.1mg/kg for SAL, p≤0.8889).  See results for details. (0.13 and 0.27 on this scale 
correspond to 1.7 and 7.1 % respectively.) 
 
Response Bias 
Response bias, the tendency to respond to the same port as on the previous 
trial, was also analyzed.  The dependent measure was the percentage of trials in a 
session on which the rat responded to the same port as the previous trial, corrected for 
the baseline response bias score for that session.  This correction was needed because 
(a) the magnitude of response bias that would be expected by chance is slightly 
affected by the pattern of correct ports in a given session; and (b) the raw response 
bias score is correlated with performance level due to the constraint imposed on the 
number of times that a given port is correct on successive trials.  
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There was a significant effect of SKF81297 dose on response bias 
[F(3,2679)=2.88, p≤0.0345], an effect apparently driven by an increased bias seen at 
the two highest doses relative to the vehicle (vehicle vs. medium:  p≤0.0703; vehicle 
vs. high: p≤0.0763)(see Figure 4.4).  In contrast, prenatal cocaine exposure did not 
affect response bias [F(1,26)=1.33, p≤0.2586], nor did this measure exhibit a 
significant Prenatal Treatment by SKF81297 interaction [F(3,2679)=1.99, p≤0.1138].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.   Effect of SKF81297 on response bias.  Response bias was significantly 
affected by SKF81297 dose (p≤0.0345), an effect that was driven, in part, by a 
borderline increase in bias produced by the two highest doses relative to the vehicle 
dose (vehicle vs. medium, p<0.0703; vehicle vs. high; p<0.0763). See Results for 
details. 
 
Pre-pokes 
Also analyzed were pre-pokes, nosepokes of < 1 sec that did not constitute a 
choice.  Two categories of pre-pokes were analyzed: early pre-pokes, those occurring 
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before illumination of the light cue and late pre-pokes, those occurring after cue 
onset.  The former were considered indicative of impulsivity whereas the latter were 
considered to reflect decision-making processes.  Data for pre-pokes were averaged 
across cue duration, delay, and timing of distractor onset (“-1” vs “-2” distractor 
conditions) to reduce the proportion of zero values in the data set. 
Prenatal cocaine exposure did not alter the incidence of early pre-pokes 
[F(1,26)=0.04, p≤0.8394], nor was there a Prenatal treatment by SKF81297 
interaction on this measure [F(3,79)=0.42, p≤0.7390].  In contrast, SKF81297 
markedly decreased the rate of this type of response [F(3,79)=11.47, p≤0.0001], 
specifically at the two higher doses (vehicle vs medium: p≤0.035; vehicle vs high: 
p≤0.0001) 
SKF81297 increased the rate of late pre-pokes [F(3,549)=33.83, p≤0.0001], 
specifically at the two higher doses (vehicle vs medium: p≤0.0088; vehicle vs high: 
p≤0.0001). However, prenatal cocaine exposure did not alter this measure 
[F(1,26)=0.26, p≤0.6158], nor was there an interaction of Prenatal Treatment and 
SKF81297 dose [F(3,549)=1.44, p≤0.2304].  
 
Response Latencies 
Prenatal cocaine exposure did not alter response latency on correct trials 
[F(1,26)= 0.21, p≤0.6541], nor was there an interaction of Prenatal Treatment and 
SKF81297 dose on this measure [F(3, 78)=1.36, p≤0.2603].  SKF81297 increased 
average response latency on correct trials [F(3, 78)=8.54, p≤0.0001], an effect limited 
to the highest dose (vehicle vs high: p≤0.0001). 
Prenatal cocaine exposure did not alter response latency on incorrect trials 
[F(1,26)= 0.62, p≤0.4398], nor was there an interaction of Prenatal Treatment and 
SKF81297 dose on this measure [F(3, 78)=0.36, p≤0.7797].  SKF81297 increased 
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average response latency on incorrect trials [F(3, 73)=9.97, p≤0.0001].  This increase 
in response latency was observed at each of the three SKF81297 doses relative to 
controls:  low (p≤0.0134), medium (p≤0.0002), and high (p≤0.0001). 
 
Alcove Latency 
SKF81297 increased mean alcove latency [F(3, 108)=16.34, p≤0.0001], 
specifically at the highest dose (vehicle vs high: p≤0.0001). However, Prenatal 
cocaine exposure did not alter mean alcove latency [F(1, 26)=0.03, p≤0.8689], nor 
was there an interaction of prenatal treatment and SKF81297 dose on this measure 
[COC*SKF:  F(3, 108)=0.11, p≤0.9554]. 
  
Nontrials 
Prenatal cocaine exposure did not alter nontrial rate [F(1,26)=0.16, p≤0.6944]. 
In addition, there was no effect of SKF81297 on this measure [F(3,485)=1.24, 
p≤0.2957], indicating that neither the drug nor the prenatal treatment affected 
motivation level on this task.  Finally, the interaction of Prenatal treatment and 
SKF81297 interaction was not significant  [F(3,485)=0.16, p≤0.9216]. 
 
DISCUSSION 
 
The results of the current study have important implications for the role of DA 
alterations in the attentional dysfunction produced by prenatal cocaine exposure, and 
for the role of D1 DA activity in normal behavior and cognition.   
SKF81297 affected numerous dependent measures in this attention task.  The 
drug decreased early prepokes and premature responses, as well as increased latencies 
and response bias, a pattern that reflects an effect of SKF81297 on DA systems 
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responsible for response initiation and selection (discussed below).  The effects of 
SKF81297 on these variables did not differ between treatment groups, suggesting that 
the DA systems responsible for these functions are unaltered by prenatal cocaine 
exposure.   
In addition, the analysis of omission errors revealed a significant interaction of 
SKF81297 and Prenatal Treatment, the critical finding considered indicative of an 
enduring effect of prenatal cocaine exposure on DA systems.   The finding that the 
statistical interaction of SKF81297 and Prenatal Treatment was only seen for omission 
errors, not for measures that appear to tap DA systems subserving response initiation 
and selection suggests that the omission error effect was mediated by DA activity in a 
different brain region(s) than these former effects.  One interpretation that fits the 
pattern of findings is that this differential effect on omission errors reflects a cocaine-
induced alteration in mesocortical DA projections underlying attention (reviewed in 
Arnsten, 1997; Pennington, 1994; Robbins, et al, 1994; Williams & Goldman-Rakic, 
1995), whereas the drug effects on response selection and initiation are likely 
mediated by effects on striatal DA neurons (Brown & Robbins, 1989a; 1989b; 1991; 
Carli, et al, 1989; Kermadi & Boussaoud, 1995; Montgomery & Buchholz, 1991; 
Robbins, 1997).  
Thus, the pattern of results, overall, suggests that the differential effect of 
SKF81297 on omission errors in the present study reflects a lasting effect of prenatal 
cocaine exposure on the DA modulation of attention.  However, it should be noted that 
because this differential sensitivity to SKF81297 was seen on a measure tapping 
sustained attention, but not on measures which tap selective attention and 
distractibility (eg premature responses, inaccurate responses), these inferred DA 
changes are not likely to have relevance for the selective attention dysfunction that has 
been reported for cocaine-exposed subjects (Gabriel and Taylor, 1998; Garavan, et al, 
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2000; Romano and Harvey, 1996; Wilkens, et al, 1998a; 1998b). However, they are 
relevant for the sustained attention deficits that have also been reported in studies of 
cocaine-exposed children (Richardson, et al, 1996) and animal models (Morgan, et al, 
1997).  For example, Richardson, et al. (1996) reported that prenatal cocaine-exposed 
children committed more omission errors than controls on the CPT, a visual attention 
task.  Omission errors in this task, as in the present study, are indicative of lapses in 
attention.  Attentional lapses also seem to contribute to the impaired performance of 
COC animals in a sustained attention task in rats (Morgan, et al, 1997).  By identifying 
the neural system likely to underlie this type of attentional dysfunction in cocaine-
exposed subjects, the present results may aid in identifying possible candidates for 
therapeutic intervention. 
It may be noted that, in the current study, attentional effects of prenatal 
cocaine exposure were only seen under the influence of SKF81297; i.e., not in the 
non-drug state.  However, prior findings from this same cohort of animals revealed 
that the COC animals were significantly impaired relative to controls in terms of both 
sustained and selective attention. Notably the impairment in selective attention was 
observed in a distraction task that is almost identical to that used in the present study 
(Morgan, et al, 1997).  Another finding from this prior study may explain why 
attentional impairment was not seen in the COC animals in the present study.  
Specifically, the magnitude of the selective attention impairment decreased with 
increasing experience on the task.  This finding suggests that the COC animals, 
despite their attentional impairment, were eventually able to filter out these 
distracting cues with extensive training with the same set of distracting cues.  There is 
every reason to believe, however, that the greater distractibility of these COC animals 
would again become apparent if novel distractors were presented, or when tested in a 
novel task.   
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The pattern of drug effects on omission errors suggests an increased 
sensitivity to SKF81297 in the cocaine-exposed animals.  Although the basis of this 
effect is not known, the most likely underlying mechanism is a lasting effect of 
prenatal cocaine exposure on DA release.  The available evidence from studies using 
similar IV cocaine exposure regimens (cocaine dose and route of administration) 
support the hypothesis that prenatal cocaine exposure increases the amount of DA 
released in response to a stressor or a pharmacological challenge, but not does alter 
basal DA levels or release.  Prenatal cocaine-exposed rabbits exhibited enhanced 
release of DA in caudate nucleus following an amphetamine challenge, relative to 
controls, whereas basal DA levels were unaffected (Du, et al, 1999).  Similarly, 
cocaine-exposed rats exhibited increased DA metabolic activity (as measured by 
DOPAC/DA ratio) relative to controls in ventral prefrontal cortex (PFC) following a 
footshock, whereas basal DA metabolic activity levels were unaffected (Elsworth, et 
al, l999; personal communication). Further support that prenatal cocaine exposure 
does not affect basal DA activity is provided by additional findings from the rabbit 
model showing no change in basal tyrosine hydroxylase immunoreactivity in 
cingulate cortex  (Wang, et al, 1996), nor in vitro DA levels in cingulate cortex, 
frontal cortex, or striatum (Wang, et al, 1995a). Finally, in an in vitro slice system, 
prenatal cocaine enhanced responsiveness of the presynaptic DA autoreceptor in 
cingulate and frontal cortices, but not striatum (Wang, et al, 1995a). Enhanced 
autoreceptor sensitivity may represent a compensatory response to this putative 
stress-induced increase in DA release (or vice versa), as these receptors provide a 
negative-feedback system.  In light of recent data suggesting that testing on PFC-
dependent tasks increases extracellular DA in PFC (Watanabe, et al, 1997), it is 
possible that the COC animals in the present study experienced excessive DA activity 
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in PFC when tested on our attentional tasks, contributing to the attentional 
impairment observed in prior tasks (Morgan, et al, 1997), discussed above. 
An alternate hypothesis is that the increased sensitivity of the COC animals to 
SKF81297 reflects an increased number or efficacy of D1 receptors.  However, this 
mechanism is unlikely based on previous findings that prenatal exposure to cocaine:  
i) did not affect D1 mRNA’s (DeBartolomeis, 1994) or receptor binding in striatum, 
nucleus accumbens, or VTA (Leslie, et al, 1994), and ii) resulted in decreased D1 
receptor G-protein coupling in striatum, anterior cingulate and frontal cortex 
(Friedman, et al, 1996; Levitt, et al, 1997; Wang, et al, 1995b).  In fact, this latter 
finding of reduced D1 coupling in IV cocaine-exposed rabbits appears inconsistent 
with the present findings.  Future research is needed to determine whether reduced D1 
receptor G-protein coupling is also seen following the particular cocaine exposure 
regimen used in the present study (route, dose, and developmental period), and if so, 
how this effect can be reconciled with the present findings.   
In light of the inconsistent findings concerning prenatal cocaine effects on 
dopamine function, additional studies are needed to clarify how the increased 
sensitivity to SKF81297’s attentional effects arises at the receptor/intra-cellular level.   
DA interactions with other neurotransmitter systems may well be involved, consistent 
with the suggestion of another study from our lab that prenatal cocaine exposure 
increases sensitivity to the behavioral effects of α2 adrenergic receptor-modulated 
DA release (Bayer, et al, 1996). 
The finding that COC animals are more sensitive than controls to the 
attentional effects of SKF81297 has functional implications.  As stress increases 
endogenous DA activity (Horger & Roth, 1996; Thierry, et al, 1976), individuals 
exposed to cocaine in utero may be more vulnerable to the adverse effects of stress 
on cognition. This hypothesis is consistent with the finding that cocaine-exposed rats 
 131 
showed increased sensitivity to the impairing effects of the pharmacological stressor 
FG-7142 on a PFC-dependent cognitive task (Murphy, et al, 1995). This 
hypothesized effect of prenatal cocaine exposure on stress-induced attentional 
impairment is also consistent with reports of altered behavioral and neurochemical 
response to stress in cocaine-exposed animals (Bilitzke & Church, 1992; Church & 
Tilak, 1996; Elsworth, et al, l999; personal communication; Goldstein, et al, 1993; 
Goodwin, et al, 1997; Johns & Noonan, 1995; Molina, et al, 1994; Wood, et al, 1993; 
1994; 1995). 
 
Implications for the cognitive roles of dopaminergic systems and D1   receptors  
In addition to delineating the mechanism for prenatal cocaine-induced attentional 
dysfunction, several observed effects of SKF81297 clarify the role of D1 DA activity 
in specific cognitive functions.  The observed pattern of results supports the 
hypothesized role of DA in response initiation and selection. SKF81297 decreased 
premature responses and early prepokes, and increased response and alcove latencies, 
suggesting that the drug altered response initiation, perhaps via activation of D1 
receptors in the striatum.  This finding corresponds with the hypothesized role of the 
mesostriatal DA system in behavioral activation and response preparation (Brown & 
Robbins, 1989a; 1989b; 1991; Carli, et al, 1985; 1989; Pullman, et al, 1988; see 
Robbins, 1997 for review).  SKF81297 also increased response bias, suggesting that 
the drug altered response selection.  This finding is consistent with the theory that 
striatal DA neurons participate in programming target acquisition and the selection of 
responses from the repertoire of available responses (Brown & Robbins, 1989a; 
1989b; 1991; Carli, et al, 1989; Kermadi & Boussaoud, 1995; Montgomery & 
Buchholz, 1991).   
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The attentional impairment produced by SKF81297, manifested as an increase in 
omission errors, provides new evidence for the hypothesized role of mesocortical DA 
in attention.  This finding corroborates the existing evidence that moderate DA 
activity in prefrontal cortex is commensurate with optimal functioning of this region, 
whereas, both suboptimal and supraoptimal DA activity impairs PFC-dependent 
functions such as working memory (Arnsten, 1997; Murphy, et al, 1996; Zahrt, et al, 
1997).   Granon and colleagues (2000) proposed that an inverted U-shaped 
relationship also exists between PFC DA activity and attention, and provided support 
for the ascending portion of the curve (i.e., attentional enhancement), using PFC 
microinfusions of the partial D1 agonist SKF38393.  The present findings, using the 
full D1 agonist SKF81297, extend these data by providing evidence for the downward 
side of the inverted U shaped curve; i.e. attentional impairment.  Finally, the present 
study, along with the report by Granon and colleagues (2000), provides important 
new evidence for an attentional role for DA activity specifically at the D1 receptor 
subtype. Although prior investigations have suggested that the D1 receptor subtype is 
most essential for PFC-dependent cognitive functions (Arnsten, 1997; Arnsten, et al, 
1994; Sawaguchi and Goldman-Rakic, 1991; 1994; Williams and Goldman-Rakic, 
1995), nearly all evidence comes from working memory, rather than attentional, 
tasks.   
In summary, the current study demonstrated that prenatal cocaine exposure 
produces enduring effects on the DA system underlying attention, but does not alter 
DA systems underlying response initiation and selection. These lasting effects on DA 
activity may contribute to the changes in attention and arousal regulation reported in 
both animals and children exposed to cocaine in utero. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The studies presented in this volume have important implications for the role 
of catecholamines in the modulation of normal attentional function.  In addition, the 
results of these studies shed light on the role played by catecholaminergic alterations 
in the attentional dysfunctions induced by environmental lead (Pb) exposure and 
prenatal cocaine exposure. All three of these issues will be discussed below. 
 
Significance of results for understanding catecholaminergic modulation of 
attention 
In Chapters 2 and 3, the effects of the alpha-2 adrenergic antagonist idazoxan 
(IDZ) provide support for the hypothesized role of NE in the modulation of attention, 
particularly selective attention and distractibility.  IDZ altered the rate of commission 
errors (inaccurate responses, inhibition errors) specifically in response to distractors. 
In chapter 2, the effect of IDZ was only observed under the 500 msec cue duration 
condition, the condition of highest attentional demand. These effects were likely 
mediated by IDZ-induced increases in LC firing, and thus increases in coeruleocortical 
NE activity (Aghajanian, et al, 1977; Dennis, et al, 1987). These results are consistent 
with evidence that activity of LC neuron was closely correlated with performance on 
visual attention tasks in monkeys (Aston-Jones, et al, 1999), and provide support for 
the theory that LC activity and cortical NE release modulate selective attention by 
reducing signal–to-noise ratio (reviewed in Aston-Jones, 1988; 1997; Foote, et al, 
1983; Sara, et al, 1988), enhancing cortical cue and delay related firing relative to 
spontaneous firing (Sawaguchi, et al, 1990). In these studies, IDZ appeared both to 
alter attentiveness to target stimuli by altering accuracy under the short cue condition 
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and to modulate attention to distractors by altering performance under conditions of 
distraction. This finding is consistent with evidence that lesions to ascending 
noradrenergic neurons in rats increase distractibility in maze tasks (Roberts, et al, 
1976) and impair performance on tasks of visual attention, specifically under 
conditions of highest attentional demand such as unpredictable target stimulus onset 
and presentation of distractors (Carli, et al, 1983; Cole and Robbins, 1992). These 
studies also provide support for prior evidence that alpha-2 selective agents alter 
performance on visual attention tasks in rats (Bunsey and Strupp, 1995; Milstein, et al, 
2007; Sagvolden, 2006; Sirvio, et al, 1993; 1994), particularly under conditions of 
greatest attentional demand such as presentation of distractors (Bunsey and Strupp; 
1995), reduced cue brightness (Sirvio, et al, 1993; 1994), and unpredictable cue onset 
(Sirvio, et al, 1993; 1994). In addition, these studies are consistent with evidence that 
alpha-2 selective agents affect distractibility in monkeys (Arnsten and Contant, 1992) 
and alter attentional performance in human subjects on the continuous performance 
task (CPT) (Coull, 1995; McClure, et al, 2007; Scahill, et al, 2001), visuo-spatial and 
visual target detection tasks of selective attention (Coull, et al, 2004; Smith, et al, 
1992; Smith and Nutt, 1996), and the Stroop task (Mair and McEntree, 1986; Taylor 
and Russo, 2001). 
The studies in Chapters 2 and 3 also provide support for the hypothesis that the 
relationship between NE activity and attention follows an inverted U-shaped curve, 
with optimal levels of NE producing optimal levels of attention and both suboptimal 
and supra-optimal levels impairing attention. IDZ increased inaccurate responses and 
impaired accuracy in male subjects as described in Chapter 3, but reduced inaccurate 
responses and improved accuracy in female subjects as shown in Chapters 2 and 3. 
This difference in the effects of IDZ is likely due to sex-related differences in 
endogenous NE activity, consistent with evidence that NE activity is higher in adult 
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male rats than females (Babstock, et al, 1997; Borsody and Weiss, 1996; Heal, et al, 
1989). The female subjects in chapters 2 and 3 likely had lower levels of endogenous 
NE activity; IDZ increased NE activity in these subjects, resulting in enhancement of 
accuracy.  In contrast, levels of endogenous NE activity were likely higher in the male 
subjects in chapter 3; in these subjects, IDZ increased NE activity beyond optimal 
levels, resulting in reduced accuracy. These findings are consistent with reports that 
the level of LC activity produces an inverted U-shaped effect on attention, with low 
levels of firing resulting in insufficient arousal and attention, moderate levels of tonic 
firing increasing attentional task performance, and high levels of tonic activity of LC 
neurons impairing vigilance and selective attention (Aston-Jones, et al, 1994). 
In Chapter 4, the observed effects of the selective D1 agonist SKF81297 have 
important implications for the role of DA activity in attentional function. Treatment 
with SKF81297 decreased subjects’ overall percent correct on a distraction task and 
the magnitude of this impairment was greatest under conditions of high attentional 
demand, the short light cue condition and the condition in which distractors were 
presented 1 sec prior to cue onset.  The impairment of performance induced by 
SKF81297 appeared to be due to a dose dependent increase in errors of omission. 
Omission error rate reflects, at least in part, lapses in focused attention. This inference 
is based on the findings from the current studies and prior studies that omission error 
rate increases as the cue duration decreases (Bayer, et al, 1994; Morgan, et al, 2001) 
and as the pre-stimulus delay increases (Bunsey and Strupp, 1995; Morgan, et al, 
2001). The effects of SKF81297 reported in chapter 4 are consistent with the results 
from a prior study using a similar distraction task in which SKF81297 selectively 
increased omission errors equally during both distraction and nondistraction trials, but 
only under the shorter (500 msec) cue duration condition, the condition requiring the 
greatest vigilance (Bayer, et al, 1994). It should be noted that SKF81297 did not 
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increase commission errors, which tap selective attention and distractibility in this 
distraction task (e.g. premature responses, inaccurate responses).   These findings 
suggest that DA activity, specifically at D1 receptors, appears to modulate the focused 
attention or vigilance component of performance on this visual attention task.  This 
interpretation is consistent with findings from a 5-choice serial reaction time task of 
sustained attention in rats on which systemic administration of the selective D1 
antagonist SCH23390 impaired performance (Passetti, et al, 2003).  Similarly 
extracellular PFC DA was elevated during task performance (Dalley, et al, 2002), and 
DOPAC/DA ratios in right frontal cortex were significantly correlated with accuracy 
on this same task (Puumala and Sirvio, 1998).  
The effects of SKF81297 on attention observed in Chapter 4 also provides new 
evidence to support the hypothesis that, like NE, DA modulation of attention also 
follows an inverted U-shaped curve, with moderate DA activity associated with 
optimal attentional processing.  In Chapter 4, SKF81297 was shown to cause 
decrements in attentional performance, suggesting that the D1 agonist increased 
subjects’ DA activity at D1 receptors beyond optimal levels, and providing support for 
the descending portion of the curve.  Support for the ascending portion of the curve 
(ie. attentional enhancement) is provided by evidence from previous studies using 
visual attention tasks in rats in which prefrontal microinfusions of SKF81297 
enhanced sustained attention (Chudasama and Robbins, 2004) and prefrontal 
microinfusions of the DA D1 receptor partial agonist SKF38393 selectively improved 
accuracy in subjects with low baseline levels of performance.  Similarly, systemic 
administration of the selective D1 antagonist SCH23390 impaired accuracy and 
increased errors of omission (Passetti, et al, 2003), and prefrontal microinfusions of 
SCH23390 selectively impaired accuracy in subjects with high baseline levels of 
performance (Granon, et al, 2000) on this same task. 
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The study in Chapter 4 examined the affects of a D1 selective agonist on 
attention, so conclusions drawn from this study about the role of DA in attention are 
limited to its effects at the D1 family of receptors, the most prevalent DA receptor 
subtype in the PFC (Lidow, et al, 1991), a critical brain region for attentional 
processing (reviewed in Arnsten, 1998; Arnsten and Li, 2005; Chudasama and 
Robbins, 2006; Robbins, 2000; 2005; Robbins and Roberts, 2007). However, recent 
evidence suggests that one of the D2 family of receptors, the D4 subtype, may also 
play an important role in the modulation of attention.  D4 receptors have been 
localized in human prefrontal cortex (Primus, et al, 1997), predominantly on 
interneurons (Mrzjak, et al, 1996). These receptors have a high affinity for NE as well 
as DA (Van Tol, et al, 1991), suggesting that this receptor subtype could contribute to 
noradrenergic-, as well as dopaminergic-modulated attentional processing. A number 
of studies have shown an association between a specific variant of the gene that codes 
for this receptor subtype, the DRD4 7-repeat allele, and attention deficit hyperactivity 
disorder (Faraone, et al, 2001; Shaw, et al, 2007; Swanson, et al, 2000). Studies with 
D-4 selective agents have provided support for a role for this receptor subtype in PFC 
dependent cognitive processes such as working memory, (Arnsten, et al, 2000; Zhang, 
et al, 2004) and attentional set-shifting (Floresco, et al, 2006). Additional studies are 
needed to determine the role of this specific DA receptor subtype in the sustained and 
selective attentional processes investigated in this volume. 
 
Cognitive effects of Pb exposure 
Pb-exposure reduced accuracy in the attention task as described in Chapter 2.  
These impairments were not limited to the trials on which distractors were presented, 
suggesting that the deficits were not related to Pb-induced increases in distractibility.  
Rather, these impairments were likely due to deficient sustained attention. Preliminary 
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analysis of data from a prior study suggested that these same Pb-exposed subjects 
showed delay-dependent impairment during the performance of a vigilance task 
(Strupp, et al, 1993), and sustained attention deficits have also been observed in 
similar vigilance tasks following some Pb exposure regimens. (Driscoll, 2003; 
Morgan, et al, 2001; Stangle, et al, 2003).  Pb-induced impairments in sustained 
attention on this task are consistent with the impairments reported on the CPT 
(Harvey, et al, 1988; Walkowiak, et al 1998) and on reaction time tasks that place 
increased demands on sustained attention in human children (Harvey, et al, 1988; 
Hunter, et al, 1985; Minder, et al, 1994; Needleman, et al, 1979; 1990; Raab, et al, 
1990). Alternately, the attentional deficits observed in the Pb-exposed subjects may 
have been related to either an increased reactivity to prior errors, consistent with the 
results of studies of early Pb-exposure from this laboratory (Morgan, et al, 2001; 
Stangle, et al, 2007), and/or to an increased sensitivity to the performance disrupting 
effects of the distractors.  This suggestion indicates that Pb-exposure may cause 
deficits in arousal regulation or the ability to deal with frustration. Such deficits in 
emotional regulation may contribute to the disruptive classroom behavior and 
increased delinquency rates associated with childhood Pb-exposure (Bellinger, et al, 
1994; Dietrich, et al, 2001; Needleman, et al, 1996). Additional studies are needed to 
determine which of these possible cognitive mechanisms underlie the observed 
attentional dysfunctions.  
Understanding the specific cognitive deficits that result in these Pb-induced 
reductions in accuracy on this task is relevant to clinical treatment of Pb-exposed 
individuals.  Chelating agents are administered to children when BPb levels exceed 40 
µg/dl, in order to rapidly remove Pb from the body.  Recent studies from our 
laboratory suggest that early treatment with the chelating agent succimer eliminates 
Pb-induced increases in emotional reactivity, specifically to errors, but is only 
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moderately successful at alleviating Pb-induced deficits in sustained attention 
(Stangle, et al, 2007), suggesting that some forms of attentional impairment may be 
unaffected by such treatment in children. Further studies in children are needed to 
evaluate the efficacy of these drugs in ameliorating specific Pb-induced cognitive 
dysfunctions.  It is likely that additional pharmacotherapy may be needed to improve 
cognitive function in affected children, as well as cognitive-behavioral interventions to 
address the specific cognitive processes that remain affected. 
 
Neurochemical basis for Pb-induced attentional impairments 
In Chapter 2, Pb-exposure caused attentional dysfunction but Pb-exposed 
subjects did not demonstrate differential sensitivity to the attentional effects of IDZ on 
this task.  This finding fails to provide evidence for the hypothesis that Pb-induced 
alterations in NE systems underlie the attentional impairment, suggesting that 
alterations in other attention modulating neurochemical systems likely mediate these 
deficits.  One plausible alternative candidate for the neural basis for these Pb-induced 
attentional impairments is the cholinergic system underlying attention; namely the 
projections from the nucleus basalis to the frontal cortex.  Pb-exposure has previously 
been shown to alter cholinergic functioning (Anwyl, et al, 1982; Bielarczyk, et al, 
1996; Bourjeily and Suszkiew, 1997; Carroll, et al, 1977; Manalis and Cooper, 1973; 
Minnema, et al, 1988; Sun, et al, 1997; Zhou, et al, 2000), and there is considerable 
evidence for cholinergic modulation of both sustained attention and selection of 
attentional targets, particularly under conditions of high attentional demand (Robbins, 
1997; 2002; 2005; Sarter, et al, 2001; 2005). Consistent with this hypothesis, recent 
studies have demonstrated differential sensitivity to the attentional effects of the 
cholinergic antagonist scopolamine and the anti-cholinesterase tacrine in early Pb-
exposed rats, using sustained attention tasks similar to the selective attention tasks 
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described in this volume.  Specifically, Pb-exposed subjects were less sensitive to both 
the attention enhancing effects of tacrine and to scopolamine-induced reductions in 
accuracy on trials following errors, which were considered a measure of emotional 
reactivity (Driscoll, 2003). In addition, Pb-exposed rats made more of this error type 
in the non-drug state following both early and chronic Pb-exposure regimens, and this 
increased reactivity to errors in Pb-exposed rats was ameliorated by treatment with the 
drug chlordiazepoxide, suggesting a possible additional role for GABA-ergic 
mechanisms in these emotional reactivity related attentional deficits (Driscoll, 2003). 
The Pb-induced accuracy deficits observed in the post-weaning Pb-exposed rats in 
Chapter 2 may have been related to increased emotional reactivity of the Pb-exposed 
rats to prior errors or to the presence of distractors on the task, suggesting that these 
deficits may be related to similar cholinergic and/or GABA-ergic mechanisms. The 
amelioration of Pb-induced attentional dysfunction observed in the chlordiazepoxide 
study also suggests the potential of benzodiazepines as possible pharmacotherapeutic 
agents to alleviate these Pb-induced deficits, although further animal model studies are 
still needed to determine the safety and efficacy of these drugs for enhancing cognitive 
function in Pb-exposed subjects.  
 An additional candidate for the basis of these Pb-induced attentional 
impairments is the DA system underlying attentional function.  As detailed above, the 
role of the DA system in attentional processes is well established, and Pb-exposure has 
been demonstrated to alter a variety of measures of central dopaminergic function.  
Specifically, studies have demonstrated amelioration of Pb-induced cognitive deficits 
in monkeys by chronic L-dopa treatment (Levin, et al, 1987), and Pb-induced 
alterations in tyrosine hydroxylase activity (Ramesh, et al, 1998), DA release 
(Struzynska, et al, 1994), DA metabolism (Lasley, et al, 1988),  DA synthesis 
(Govoni, et al, 1979),  and DA turnover (Lasley, et al, 1984).  Following Pb exposure, 
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striatal DA levels decrease (Minnema, et al, 1986), which may cause compensatory 
supersensitivity of DA receptors (Cory-Slechta, et al, 1992).  Alterations in sensitivity 
to peripherally administered dopaminergic compounds have also been demonstrated in 
rats using operant tasks (Cory-Slechta, et al, 1991; 1992).  Although these findings 
suggest that the DA system is altered following Pb-exposure, additional studies from 
our lab shed light on the hypothesis that these DA alterations mediate Pb-induced 
attentional deficits.  Specifically, subjects exposed to the same chronic post-weaning 
regimen utilized in chapter 2 or to a model of developmental Pb-exposure did not 
appear to be differentially sensitive to the impairing effects of either the selective D1 
agonist SKF81297 or the selective D1 antagonist SCH23390 on the same attentional 
tasks used in this volume (Bayer, et al, 1994; Bayer and Strupp, unpublished data). 
These findings fail to provide evidence that alterations in DA activity, specifically at 
D1 receptors, underlie the Pb-induced deficits demonstrated on our task of visual 
attention. Further studies are needed to investigate the role of DA activity at D2 
receptor subtypes in this dysfunction, as there is some evidence for D2 receptor 
modulation of some aspects of attentional function (Harrison, et al, 1997; Mehta, et al, 
1999; Passetti, et al, 2003). The selective D2 antagonist sulpiride is a good candidate 
for pharmacological challenge studies investigating this hypothesis, because, unlike 
other D2 selective agents, it has demonstrated effects on performance on a similar 
visual attention task in rats (Harrison, et al, 1997; Passetti, et al, 2003) and in human 
tasks of attentional set-shifting (Mehta, et al, 1999). In light of recent evidence for the 
role of the D4 subtype of D2-type receptors in attentional dysfunctions (Faraone, et al, 
2001; Shaw, et al, 2007; Swanson, et al, 2000), studies investigating the effects of 
selective D4 agents on attention in Pb-exposed rats would also be warranted. These 
additional drug challenge studies may help identify additional potential 
pharmacotherapeutic agents for the treatment of affected children. 
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Lasting effects of prenatal cocaine exposure on catecholaminergic modulation of 
attention 
  The pharmacological challenge studies in Chapters 3 and 4 provide evidence 
that prenatal cocaine exposure produces lasting changes in the catecholaminergic 
modulation of sustained attention.  In Chapter 4, prenatal cocaine exposed rats were 
more sensitive to the impairing effects of the D1 DA receptor agonist SKF81297 on 
omission errors, an error type indicative of lapses in attention.  In chapter 3, prenatal 
cocaine exposure also increased sensitivity to the effects of IDZ on this same error 
type, an effect that likely reflected IDZ-induced increases in NE-modulated dopamine 
activity.  Taken together, these results suggest that prenatal cocaine-induced deficits 
in sustained attention may be due to increased sensitivity to DA activity, an effect 
which is likely mediated by prenatal cocaine-induced increases in stimulated DA 
release. This hypothesis is consistent with evidence from previous studies using 
similar IV cocaine exposure regimens that suggest that prenatal cocaine exposure 
does not alter basal DA levels or release (Du, et al., 1999; Elsworth, et al., l999; 
Wang et al, 1995; 1996), but does increase the amount of DA released in response to 
a stressor or a pharmacological challenge (Du, et al., 1999; Elsworth, et al., l999; 
Morrow, et al., 2001; Murphy, et al., 1995). There is evidence that testing on PFC-
dependent tasks increases extracellular DA in PFC (Watanabe, et al., 1997), 
suggesting that the prenatal cocaine-exposed subjects in the present studies may have 
experienced increased DA release in PFC relative to controls when tested on our 
attentional tasks.  This increased DA activity may have contributed to both the 
deficits in sustained attention observed in prior tasks (Morgan, et al., 1997), and to 
the increased sensitivity to the attentional effects of SKF81297 demonstrated in 
chapter 4. Systemic injections of alpha-2 adrenergic agents modulate stress-induced 
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increases in DA turnover (Morrow, et al., 2004) by regulating activity in the ventral 
tegmental area (Grenhoff and Svensson, 1988; Grenhoff  and Svensson, 1989; 
Morrow, et al., 2004), suggesting that this differential dopaminergic response to 
stress or pharmacological challenge seen following prenatal cocaine exposure may be 
due to lasting alterations in NE-modulated DA release. Additional studies are needed 
to differentiate between lasting effects of the early drug exposure on the NE and/or 
the DA components of this system and to clarify how the increased sensitivity to the 
attentional effects of these agents arises at the receptor/intra-cellular level. 
The increased sensitivity to DA activity demonstrated by prenatal cocaine-
exposed subjects in Chapters 3 and 4 has important implications for the effects of 
stress on children exposed to cocaine in utero.  Stress increases endogenous levels of 
NE and DA activity (Horger & Roth, 1996; Thierry, et al., 1976) and impairs 
prefrontal cognitive functions such as working memory (Arnsten and Goldman-Rakic, 
1998) and attention (Hartley and Adams, 1974; Hockey, 1970).  These stress-induced 
cognitive impairments have been shown to correlate with the amount of DA turnover 
in PFC (Murphy, et al, 1996a; 1996b). Individuals exposed to cocaine in utero may be 
more vulnerable to these adverse effects of stress on cognition. This hypothesis is 
consistent with the finding that prenatal cocaine-exposed rats showed increased 
sensitivity to the impairing effects of the pharmacological stressor FG-7142 on a PFC-
dependent working memory task (Murphy, et al., 1995). This hypothesized effect of 
prenatal cocaine exposure on stress-induced attentional impairment is also consistent 
with reports of altered behavioral and neurochemical response to stress in cocaine-
exposed animals (Bilitzke & Church, 1992; Church & Tilak, 1996; Elsworth, et al., 
l999; 2007; Goldstein, et al., 1993; Goodwin, et al., 1997; Johns & Noonan, 1995; 
Molina, et al., 1994; Morrow, et al, 2001; Wood, et al., 1993; 1994; 1995). Future 
research is needed to confirm whether the particular cocaine exposure regimen used in 
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the present studies increases sensitivity to stress-induced attentional impairment, and 
whether this increased sensitivity can be ameliorated by treatment with selective D1 or 
D4 antagonists, or with neuroleptic drugs such as clozapine or haloperidol that block 
DA and alpha-1 adrenergic receptors.  These drugs have demonstrated success in 
reversing the deficits in PFC cognitive functions caused by stress-induced increases in 
DA activity in animal subjects (Arnsten and Goldman-Rakic, 1998; Arnsten, et al, 
2000; Murphy, et al, 1996), and may have potential for the development of 
pharmacotherapeutic agents for the treatment of similar dysfunction in children 
exposed to cocaine in utero.  In addition, further behavioral pharmacology studies with 
the drug guanfacine may provide further information about the basis and potential 
treatment of the observed prenatal cocaine-induced attentional impairments. 
Guanfacine, an alpha-2 adrenergic agonist used in the treatment of ADHD, has been 
demonstrated to improve ADHD patient performance on both standard ADHD 
symptom rating scales (Hunt, et al, 1995; Scahill, et al, 2001; Taylor and Russo, 2001) 
and on more specific tests of attention such as the CPT (Scahill, et al, 2001) and the 
Stroop task (Taylor and Russo, 2001).  Additional drug challenge studies could 
determine whether guanfacine can ameliorate the types of attentional dysfunctions 
demonstrated by this same cohort of subjects in prior studies (Morgan, et al, 2002), 
shedding light on the potential use of this drug as a possible treatment for affected 
children.  Finally, the suggestion that prenatal cocaine exposure may increase the 
adverse effects of stress on attentional function suggests that cognitive and behavioral 
interventions that focus on stress reduction may be beneficial to affected children.  
 
 In conclusion, the current studies demonstrated that dopaminergic and 
noradrenergic systems modulate specific and different aspects of attentional 
processing.  The studies with Pb-exposed rats revealed that chronic post-weaning Pb 
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exposure causes impairments in sustained attention and/or emotional regulation, but 
these deficits are not related to changes in the noradrenergic modulation of attention. 
In contrast, the lasting impairments in sustained attention caused by prenatal cocaine 
exposure appear to be related to lasting alterations in NE-modulated DA release.  
These data provide a basic science contribution to the study of the pharmacology of 
sustained and selective attention and distractibility.  In addition, they have applied 
value in the development of potential pharmacotherapies for children affected by these 
developmental toxins. 
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